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ABSTRACT
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FIBROBLAST TO MYOFIBROBLAST PHENOCONVERSION

May 2019
Arpa Samadder, B.S, M.S., University of Massachusetts Boston

Directed by Professor Todd Riley

Unlike the genome, cell transcriptome is dynamic and specific for a given cell developmental
stage. Transcriptomics study is crucial to understand the functional elements of the genome to
divulge molecular constituents of cells. The recent development of high-throughput sequencing
technologies has provided an unprecedented method to sequence RNA and it has been
emerging as the preferred technology for both characterization and quantification of the cell
transcripts. Using “Tailor_Pipeline” we have analyzed diet-induced mouse and stromal
fibroblast RNA-Seq samples and deciphers the differentially expressed genes that were
significantly up- and downregulated and associated with several metabolic immune responses
that presumably associated with liver disease. Analyzing the diet-induced mice model allowed
us to encapsulate the transcriptional differences between diet-induced mice that can aid in the
understanding of NAFLD and consequent liver pathogenesis. Identification of genes
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downregulated in metabolic processes and upregulated in immune responses indicate that mice
model exhibiting liver disease. Moreover, the finding of a premalignant signature suggests that
NAFLD may begin to progress towards hepatocellular carcinoma much earlier than earlier
consideration.
Tissue fibrosis arises due to overgrowth, scarring of various tissues and is attributed to
deposition of the extracellular matrix including collagen, influenced by the actions of several
pro-fibrotic proteins that can induce myofibroblast phenoconversion. Though recent
transcriptomics analysis reveals cellular identity, but its ability to provide biologically
meaningful insights in fibrosis is largely unexplored. To unravel the mechanisms at the genetic
level, we have considered TGFβ/TGFβR and CXCL12/CXCR4 transcriptomes in human
stromal fibroblasts. Transcriptome profiling technology revealed CXCL12/CXCR4 axis is
responsible for the activation of COPII vesicle formation, ubiquitination, and Golgi/ER
localization/targeting. Especially, identification of CUL3 and KLHL12 are responsible for the
transportation of procollagen from ER to the Golgi. Interestingly, over-expression of CUL3
and KLHL12 are highly correlated with procollagen secretion by CXCL12-treated cells, but
not in TGFβ-, treated cells. Moreover, this analysis showed how activation of the
CXCL12/CXCR4 axis promotes procollagen I secretion that responsible for the deposition of
ECM which is a characteristic of fibrosis.
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CHAPTER 1
INTRODUCTION
1.1 Context and motivation
The chemistry Nobel Prize was awarded to Fred Sanger and Walter Gilbert, in 1980, for their
crucial contribution towards the determination of base sequences in nucleic acids (Sanger et
al., 1977 & Gilbert et al., 1973), since then many were involved in the developments of DNA
sequencing technologies (Fiers et al., 1976). Development of these techniques conveyed a
modernized approach to biological questions and, high throughput sequencing technologies
such as RNA-Sequencing (RNA-Seq) has revolutionized the post genomic era, become an
integral part of the biological research to access the cell transcriptome (Mardis, 2008).
Bioinformatics is an interdisciplinary field that integrates computer science and
biology to research, develop, and apply computational tools to manage and process large
scale of biological data (Hogeweg and Hesper, 1978). Particularly, these computational tools
are suitable to analyse data generated from high-throughput sequencing platforms.
Consequently, the success of next-generation sequencing (NGS) technologies is strongly
related with the creation of competent computational tools to deal with the dramatic increase
of data (Shendure and Ji, 2008).
Until the mid-1990s, gene expression studies were limited to measure transcription of
few genes. But microarray technology changed this and allowed the study of hundreds or
thousands of transcripts at a time. At that time, this technology revolutionized many areas of
biology, from basic research to the understanding and treatment of human disease (Schena et
al., 1995). In an analogous way, the recent availability of next-generation sequencing (NGS)
analysis has opened new horizons to address the gene expression analysis, where initially
NGS applications were mainly focusing on the sequencing of genomic DNA, this technology
is now finding its way to be used in transcriptomics studies (Westermann et al., 2012).
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An important biological aspect in recent year is to understand the complex and
sophisticated mechanisms where deposition of the extracellular matrix (ECM) leads to
develop progressive aging- and inflammation-associated fibrosis. Now tissue stiffness and
urethral disfunction are due to the accumulation of ECM that leads to reduce tissue flexibility
that lead to urinary flow block and development of lower urinary tract symptoms (LUTS). In
this study, we have tried to encapsulate whether senescence-accelerated mouse prone
(SAMP6) mice would also develop LUTS. Also, we have tried to see whether diet-induced
obesity and type 2 Diabetes Mellitus (T2DM) have any influential role to propagate this
disease. A global transcriptomics analysis can provide new insights into the disease process,
leading to the identification of known and unknown transcripts, and overall gene expression
regulation of different pathways and how they differ between the different samples under
different diets (Gharaee-Kermani et al., 2013).
Dynamic remodeling of the extracellular matrix (ECM) deposition and gain an
understanding of their role in fibrosis is a challenging factor recently. Fibrosis characterizes a
contributing factor to the etiology of LUTS (Gharaee-Kermani et al., 2013). Several studies
have shown that the aging prostate tissue is rich with inflammatory cells microenvironment
and proteins. It is still unclear whether these inflammatory proteins, particularly CXC-type
chemokines, can mediate fibroblast to myofibroblast phenoconversion and the ECM
deposition which necessary for the development of prostatic tissue fibrosis (RodríguezNieves et al., 2016). In human stromal fibroblast, we are trying to determine the effect of
TGFβ/TGFβR and CXCL12/CXCR4 transcriptomes and find out the difference between
them. In addition to this we aimed to find out any significantly differentially expressed
transcripts including coding and non-coding mRNAs that may promote myofibroblast
phenoconversion.
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1.2 Problem formulation
This thesis has two underlying goals that are complementary to each other: the first is related
to computational methodologies and the second to biologic knowledge.
•

Computational goal

Firstly, I aim to integrate available bioinformatics tools in a congruent pipeline that can
process RNA-Seq data and extract reliable biological conclusions from it.
•

Biological goal

The second main goal is to use the developed tools to comprehend in which way NAFLD
(Non-Alcoholic Fatty Liver Disease) is transcriptionally regulated. Furthermore, it has
been well informed that tissue fibrosis is mediated by the actions of multiple pro-fibrotic
proteins that can induce fibroblast to myofibroblast phenoconversion. This occurs through
various signaling pathways such as Smads or MEK/Erk proteins. Apart from that the
TGFβ/TGFβR and CXCL12/CXCR4 axes persuade myofibroblast phenoconversion
independently through Smads and MEK/Erk proteins, respectively. To investigate these
mechanisms at the genetic level, we aim is to elucidate the TGFβ/TGFβR and
CXCL12/CXCR4 transcriptomes in human fibroblasts.
1.3 Thesis Outline
Apart from this introduction, this thesis is structured in six chapters.
In chapter 2 I introduce the concept of gene expression, its main regulation points and
the several used approaches to have insight into this information. Particularly, in section 2.4, I
give special relevance to RNA-Seq data and the current methods that are used to access the
gene expression profile and extract novel biological knowledge from this type of data.
Chapter 3 presents a review on the diet-induce obesity mouse model to characterize
the transcriptional landscape of NAFLD and compare it to the transcriptional signature of
healthy control mice. More importantly, identification of the transcriptional signatures helps
to detect of these diseases through the identification of novel markers. Moreover, in this
3

chapter, it is described the RNA-Seq mouse dataset that will be used in this thesis as a case
study to test the developed ethodologies.
Then, in chapter 4 I describe a pipeline developed to analyze an RNA-Seq dataset. As
a case study, I used the implemented pipeline to process an RNA-Seq dataset extracted from
SAMP6 strain mouse fed with high fat diet (HFD) and low-fat diet (LFD). From its output I
conclude whether there are any significant transcript differences between the two phenotypes,
up-regulating inflammation-related processes and down-regulating metabolism related
processes in HFD-fed mice compared to LFD-fed mice. This analysis is described in section
4.2. Then in section 4.3 I have discussed the detailed analysis of human fibroblast cell line
where we have elucidated the TGFβ/TGFβR and CXCL12/CXCR4 transcriptomes in human
fibroblasts. From the output I conclude the biological significance about the fibroblast to
myofibroblast phenoconversion.
Afterwards, in chapter 5, I have described the detail analysis of two case studies done
by using our recently developed pipeline known as Tailor_Pipeline.
Then, in chapter 6 I have discussed the overall journey of this analysis and how this
pipeline helps to analyze the raw RNA-Seq data to extract the biological significance.
Finally, in chapter 7 I have concluded the important aspects of the analysis.
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CHAPTER 2
GENE EXPRESSION
2.1 Introductory note
Eukaryotic organisms have its genetic information encoded in molecules of
deoxyribonucleic acid (DNA) which are packed and organized into the cell nucleus in
structures called chromosomes. The monomers of DNA are called nucleotides and they are
organized in a double-stranded helix. Nucleotides are comprised by a phosphate group, a 5carbon sugar, and a nitrogenous base. The genetic information in a DNA molecule is
represented by the sequence of nucleotides containing one of four types of nucleobases:
adenine (A), guanine (G), cytosine (C) and thymine (T).
Following the Watson - Crick Model (Watson and Crick, 1953), the two strands that
constitute the DNA molecule are held together by hydrogen bonds that can only be
established between specific pairs of nucleobases: A with T and G with C. Because of this
restriction, both strains are complementary to one another and, therefore, contain the same
genetic information.
2.2 The concept of gene expression
In 1958, the central dogma of molecular biology was firstly proposed by Francis Crick
(Crick, 1958; Crick 1060). Particularly, central dogma states that information in nucleic acids
can be transferred (Fig-1). Gene expression is the process by which a segment of DNA is
copied into a ribonucleic acid (RNA) molecule which, in turn, will be used in the synthesis of
functional gene products. Some RNA molecules can be the end product in themselves and
some can be used as a template for the creation of other molecules such as proteins, in a
process called translation. According to this distinction, RNAs can be classified as either
messenger RNAs (mRNAs) or non-coding RNAs (ncRNAs). The genetic information is
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transferred into an RNA molecule is designated by transcription and completed in the cell
nucleus by an enzyme called RNA polymerase (RNA pol).
The RNA polymerase catalyzes and forms the phosphodiester bonds that link the nucleotides
together and form the sugar-phosphate backbone. In eukaryotes, there are multiple types of
RNA polymerases (RNA pol) that synthesize various types of RNA. Firstly, RNA pol I
transcribe ribosomal RNAs (rRNAs) which associated with ribosomal proteins, on which
mRNA is translated into protein. Secondly, RNA pol II transcribes mainly protein-coding
genes (mRNAs). Finally, RNA pol III catalyzes the transcription of transfer RNAs (tRNAs),
which function as adaptors selecting amino acids and holding them in place on a ribosome for
their incorporation into protein. As we have seen, DNA to protein synthesis occurs in a twostep process. In the first step DNA to mRNA synthesis is called transcription. In the second
step, called translation where the information in the mRNA is translated into protein.
The transcription is a process of formation of the transcript (RNA). It takes place by the usual
process of complementary base pairing, catalyzed and scrutinized by the enzyme RNA
polymerase. It occurs unidirectionally in which RNA chain (transcript) is synthesized from 5′
to 3′ direction. Initiation, elongation, and termination are the three steps of the gene
transcription process. Initiation process begins when the RNA pol molecule binds to the
upstream region of the DNA at a specialized sequence called promoter. To occur this binding,
RNA polymerase requires the involvement of many accessory proteins such as transcription
factors (TFs). The transcription initiation complex can be formed by the combination of the
transcription factors and RNA polymerase and this complex is responsible to initiate
transcription. The RNA polymerase started to synthesize mRNA by corresponding
complementary bases to the original DNA strand. These must assemble on promoter along
with the polymerase before the polymerase can begin transcription. Once transcription is
initiated, most of the TFs are released from the DNA. Elongation involves the movement of
the transcription bubble by disruption of DNA structure. The enzyme moves along the DNA
6

and extends the growing RNA chain. As the enzyme moves, it unwinds the DNA helix to
expose a new segment of the template in single-stranded condition and added nucleotides to
the 3´ end of the growing RNA chain. Finally, transcription termination occurs after RNA pol
reaches a termination site. At this point, RNA pol is released from the DNA and RNA is
cleaved and released from the transcriptional complex.
Simultaneously to the transcription process, the translation takes place in the cytoplasm.
The mRNA molecules undergo little or no modification after synthesis by RNA polymerase
in prokaryotes. In contrast, processing of eukaryotic pre-mRNA involves 5’ capping, 3′
cleavage/Polyadenylation, splicing, and RNA editing before being transported to the
cytoplasm where they are translated by the ribosome. Polyadenylation is an important RNA
processing step where a long chain of adenine nucleotides is added to a messenger RNA
(mRNA) molecule to increase the stability of the molecule, aiding its exportation from the
nucleus to the cell cytosol. In this process, a series of repeated A nucleotides – poly-(A) tail –
are added to the 3′ end of the pre-mRNA molecule. First, the 3' end of the transcript is
cleaved and generate a 3' hydroxyl and poly-A polymerase (PAPs) adds a chain of adenine
nucleotides up to 250 residues to the RNA. The poly-A tail provides stability of the RNA
molecule and prevents its degradation.
Furthermore, in the cell nucleus, the newly synthesized RNA molecules require extensive
processing to become a functional RNA. In most eukaryotic genes, noncoding DNA is also
found.
Such genes have split structures in which segments of coding sequence (called exons)
are separated by noncoding sequences (intervening sequences, or introns). In the mRNA, the
introns are then removed by splicing and yield a long RNA molecule which possess only
exonic part. In a process designated by splicing, introns are removed from the mRNA
molecule and then neighboring exons are stitched together. This process is exclusive of
eukaryotic organisms.
7

The mature RNA is then selectively transported from the nucleus to the cytoplasm
where mRNAs are involved in the translation process, where the information in an mRNA
molecule is converted into a protein. In this process, an mRNA molecule is used as a template
by a ribosome, which will match each sequence of three nucleotides (codon) on the template
mRNA chain with a sequence of three complementary nucleotides (anti-codon) on a tRNA
molecule. Bearing in mind that each tRNA has connected to an amino acid that its anti-codon
sequence calls for, this molecule will recognize and bind to a codon at one site and to an
amino acid at another site of its surface. Thus, tRNAs function as translators between
nucleotide sequences in RNAs and amino acid sequences in proteins. The ribosome, as the
mRNA moves through it, covalently links each amino acid to the end of the growing
polypeptide chain by peptide bonds. When the translation reaches a Stop codon, denoting the
end of the protein, the completed protein chain and the mRNA molecule are released, and the
ribosome is dissociated into two separated subunits.
Therefore, gene expression can be seen, as a mediator that interprets the genetic
information of an organism (genotype) that gives rise to an outward physical manifestation
(phenotype), via gene transcription and mRNA processing.
2.3 Gene expression regulation:
Given that genes encode for proteins and proteins dictate the function of the cell and
their structural proprieties. Each step of the gene expression is associated with the flow of
information from DNA to RNA to protein that provides the cell with a probable control point
for self-regulating that associated with its function. This allows cells to respond to maintain
their cell-type specific expression patterns.
In this way a cell can regulate the amount and type of proteins that it is manufacturing by
several key factors:
1. Required controlling when and how often a given set gene is transcribed;
2. To control processing of an RNA transcript;
8

3. To select which mRNAs are exported from the nucleus to the cytosol;
4. Degradation of certain mRNA molecules;
5. Selecting for which mRNAs are translated by ribosomes;
6. Selectively activating or inactivating proteins after they have been synthesized;
7. Controlling of mRNA degradation.
2.3.1 Transcriptional regulation
Transcriptional regulation plays a paramount role in controlling gene expression.
During this process no, unnecessary intermediates are synthesized. This regulation can be
executed at the promoter level by the association of TFs to the gene promoter region. As
referred in section 2.2, the establishment of this connection will help to bind the RNA pol to
initiate translation process. In the promoter region, nearly all genes are controlled by
regulatory DNAs that may increase or decrease the activity of transcription of a certain gene.
Now enhancers are sequence-specific TFs generally bind to these regulatory DNA regions
and can control the switching on or off a gene, respectively. Often, the sequence specific
factors and the general TFs accumulated in the promoter region and interacted via additional
proteins named as co-factors. Rate of regulation of gene transcription is controlled by
aiding/preventing the assembly of the general TFs and RNA pol at the promoter region
(Kreimer and Pe’er, 2013). To bind the TFs and the RNA pol to the regulatory regions of the
gene, the DNA chain needs to be accessible.
Hence, the activity of transcriptional regulation can be also influenced by the level of DNA
packaging. DNA is usually densely packed with histones, forming a closely packed structure
called chromatin. Chromatin construction allows access of condensed genomic DNA to the
regulatory transcription machinery proteins, and thereby controls the efficiency to initiate the
transcription initiation. (Oberdoerffer et al., 2008). After transcription initiation, the activity
rate of the RNA pol II enzyme is decreased and paused on a promoter proximal position.
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From this stage, depending on the type of transcription elongation factor that interacts with
the RNA pol II, transcription may halt or enter elongation phase (Dvir et al., 1997).
2.3.2 Post-transcriptional regulation
During RNA synthesis, post-transcriptional regulation controls the gene expression.
It contributes considerably to regulate gene expression across human tissues. The process of
polyadenylation, introduced in section 2.2, influences the transcripts lifetime, protecting them
from degradation and aiding their exportation to the cell cytosol.
In a similar way, modulating the capping, splicing, addition of a Poly (A) tail where a
modified guanine nucleotide cap is added to the 5′ end of pre-mRNA molecules is crucial for
the novel transcript to exit the cell nucleus. Therefore, both these processes are essential for
the stability of the mRNA molecule into an ideal time-window. The process of splicing, also
referred in section 2.2, enables the production of mature messenger from a newly
made precursor messenger RNA (pre-mRNA) transcript. During RNA splicing the introns are
precisely excised and the exons are ligated together. The majority of nuclear pre-mRNA is
spliced constitutively; that is, only one mature mRNA species is generated from a single premRNA in all tissues. In some cases, however, alternative 5′ and/ or 3′ splice sites are used
during splicing, resulting in the production of more than one mRNA species from a single
pre-mRNA. The production of different RNA products from a single product by changes in
the usage of splicing junctions is known as alternative splicing. During this alternative
splicing, the alternative 5′ and/or 3′ splice sites can result in structurally distinct mRNAs by
either excluding potential exon sequences or incorporating otherwise noncoding introns
sequences.
2.3.3 Translational regulation
Translation takes place in the cytoplasm. Some parts of the cytoplasm are so tightly
packed with the soluble protein and cytoskeleton that ribosomes can be expected to have
difficulties diffusing into them. This is usually performed by biding a repressor to the 5′
10

untranslated region of the mRNA, which helps to guide the ribosome to the mRNA start
codon. The ribosome is, thereby, kept from finding the translation start site. When conditions
change, the cell can inactivate the repressor and increase translation of the mRNA.
Regulation of the rate of protein synthesis is involved by the influencing the rate-limiting
steps of the translational steps. Now, this process can be accomplished by the involvement of
ribosomes or initiation factors. Generally, cytoplasmic mRNAs are actively translated by
ribosomes to form messenger ribonuleoprotein particles, mRNP. Translational initiation
process involved by utilizing two subunits: eIF2 and eIF4E. eIF4A, eIF4G and eIF4F are
other subunits, involved in the initiation of translation process. In most cells, the availability
of the eIF-4E which is a cap-binding protein is the rate-limiting factor involves initiating
translation. Therefore, regulation of eIF-4E levels is important to control the rate of
translation.
2.3.4 Protein degradation
Once protein synthesis is complete the level of expression of that protein can be
reduced by protein degradation. Cells possess specialized pathways to degrade proteins, using
enzymes designated by proteases. In these pathways, proteins which lifetime must be short,
or which are damaged or misfolded are marked by the attachment of a small protein called
ubiquitin. Ubiquitylated proteins are then recognized and destroyed.
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CHAPTER 3
GENE EXPRESSION ANALYSIS BY RNA-SEQUENCING DATA
3.1 Approaches for genome-wide expression analysis:
It is worth mentioning that high-throughput sequencing becoming a prime choice to
measure the gene expression to get an insight about the transcriptional behavior of biological
systems. Therefore, identification of differential gene is an important paradigm that is used
in many areas of biology and medicine. It can be employed to identify significantly
differentially expressed genes between two or more biological conditions of interest (Schena
et al., 1995). To classify heterogeneous diseases such as cancer, differentially gene
expression analysis plays a pivotal role (Bhattacharjee et al., 2001). This analysis is also
important to understand the relation between genes profile and survival or tumor
aggressiveness (Veer et al., 2002). To discover new drugs (Pagliarulo et al., 2002), diagnose
diseases (Heller et al., 1997), differentially gene expression is important (Thiery et al., 2006).
Gene expression analysis can be divided into two parts namely genome-wide and
target-based approach, depending on what it is anticipated to study. In the absence of any key
genes of interest, the data is acquired at the biological system level. Therefore genome-wide
approaches such as microarrays (Augenlicht and Kobrin, 1982) or RNA-Seq (Mortazavi A et
al., 2008) technologies have emerged as a powerful technology for the detection of
differential gene expression, that enables to quantify the frequency of RNA species in a
certain biological system. Transcriptome profiling which is defined by the complete set of
transcripts in a cell and their amount at a definite acquisition point is the main approach to
measure the differential gene expression. As stated in section 2.2, knowledge of the
transcriptome is very useful to provide a link between change of expression of a gene and
their phenotype presented by the cell (Wang et al., 2009). On the contrary, polymerase chain
reaction (qPCR) should be employed when the genes of interest are already known (Murphy
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L D et al., 1990). The main purpose of this reaction is to perform the gene expression
analysis. Here I have mainly focused on genome-wide GEA, particularly those using RNASeq technology and explain the pros and cons associated with this analysis. Furthermore, I
will also include the brief RNA-Seq protocol and revisit the current methodologies which are
associated to assess from the raw nucleotides sequence and their active cellular processes
upon collection of the transcriptome.
To perform transcriptomics analysis an ample number of technologies have been
developed over the years. Out of all these methods, High-throughput sequencing technology
has endowed with an unprecedented aspect about the transcriptional landscape of an
organism and becoming the paradigm to measure RNA expression levels. With the dawn of
sequencing technology, it’s now feasible to profile gene expression levels in every field in
life sciences and becoming prevailing technique for clinical use. Generally, one of the main
goals of this experiment is to identify the differential gene expression, gene isoform, post
transcriptional modifications and so on to understand phenotypic variation (Rapaport et al.,
2015).
Understanding the large-scale studies of gene expression levels, a microarray was a
tool to detect the gene expression in the 1990s. Concurrently, the process of measuring the
gene expression, microarray can provide a picturesque of transcriptional activity in a wide
range of biological problems, including identification of differentially expressed genes
between diseased and healthy tissue (Zhao et al., 2014). Currently, DNA microarrays are a
relatively inexpensive and can afford many laboratories for transcript profiling. In
microarray, a short single stranded DNA molecule, called probes, are attached to fixed
locations on a solid substrate. Then RNA molecules (transcriptome) are extracted from the
sample and copied into complementary DNA (cDNA) with the help of reverse transcriptase.
Fluorescent dye was used to label in the cDNA. Finally, cDNA is passed over the solid
support and complementary sequence will tend to hybridize. Then expression is quantified by
13

using a fluorescence scanner that measures the amount of fluorescence coming from each
probe on the slide (Hoheisel, 2006).
In biological samples, gene expression microarray profiling endowed with precise
determination of expression levels of genes in a single hybridization experiment.
Identification of nearly 57000 citations by using a simple search for the term “microarray” in
PubMed database shows its consequence for assaying gene expression. However, the power
of this technology has several drawbacks. For instance, due to cross-hybridization, the
expression measurements have high background levels. Therefore, the probe sequences must
be pre-specified so that priori the sequences can be identified. Additionally, due to both
background and saturation signals, the accuracy of measurement of expression is limited
(Okoniewski and Miller, 2006). In order to overcome this limitation probes should be used
that can differ in their hybridization properties. Otherwise it is unreliable to compare the
same array between different genes (Gautier et al., 2004). Therefore, it’s crucial to maintain
the experimental design to perform successful microarray experiment. In order to perform
successful experiment, sometimes a major question whether the microarray experiment
should be performed using the single-color or two-color to compare the relative gene
expression. Until date lot of articles have been published reading this issue saying that singlecolor arrays are more flexible in analysis compare to the two-color. Anyway, in contrast to
the microarray technology, some sequence-based methods are also important to determine the
cDNA sequence. Previously, Sanger sequencing was performed to determine the cDNA
sequence (Sanger et al., 2004). However, Sanger sequencing is expensive and have relatively
low throughput and generally is not quantitative (Wang et al., 2009). To overcome these
limitations, tag-based methods were developed namely serial analysis of gene expression
(SAGE) (Velculescu et al., 1995), cap analysis of gene expression (CAGE) (Shiraki et al.,
2003) and massively parallel signature sequencing (MPSS) (Brenner et al., 2000). However,
SAGE based technology doesn’t measure the actual expression level of a gene. During SAGE
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analysis, short tag (ten bases) has been produced, makes the analysis hard to assign a tag to a
specific transcript with accuracy because these short tags can be mapped to more than one
place in the reference genome, allowing an ambiguous identification of transcripts.
Sometimes, same tag possesses with the two different genes and the alternatively spliced
gene could have different tags at 3′ ends.
Finally, with an emergence of high-throughput sequencing technologies have
overcome the limitations of both microarrays and tag-based methodologies (Church, 2006).
Specially, RNA-Seq is a transcriptome profiling technology and NGS platform for
differential gene expression (Mardis, 2008). Particularly, RNA-Seq technology is more
reliable to arrays and employed for both mapping and quantifying transcriptome across all
cell types, perturbation and states (Roberts et al., 2011). RNA-Seq technology is more
persuasive and quantifies the expression of novel transcript over a wider dynamic range
which is not possible to quantify in array-based technology (Marioni et al., 2008). Due to
hybridization-free approach, this technique has been widely used in an integral part of
microbiological research (Mardis, 2008). Additionally, RNA-Seq technology can be used to
detect of gene fusion events (Maher et al., 2009), detection of single nucleotide
polymorphisms (Mardis, 2008), investigation of post transcriptional RNA mutations (Garcion
et al., 2004), study of alternative splicing events (Pan et al., 2008), discovery of novel
transcripts (Guttman et al., 2010; Degner et al., 2009). Of course, in near future, the probable
technical goal is to sequence and count entire mRNA molecules known as single-molecule
sequencing which enable to quantify even single cells.
3.2 RNA-Sequencing experiment workflow
In all living organisms, RNA molecules are crucial components and several highthroughput sequencing techniques are existing to interrogate of RNA sequences on a large
scale. Currently, 454 GS-FLX from Roche 454 Life Science, Genome Analyzer II from
Illumina, Inc. and AB SOLiD from Applied Biosystems are believed to be the foremost
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method in expression analysis. However, different technologies require different
experimental procedures for sequencing study. In principle, any high-throughput sequencing
technology can be used for the RNA-Seq study and Illumina’s machines have already been
applied for the purpose (Bennett, 2004). In RNA-Seq study, after conversion to a library of
cDNA fragments with adapters attached to one or both ends and sequenced in a highthroughput way to get the short reads (Wang et al., 2009). The resulting reads are either
mapped to a reference genome or de novo without genomic sequence to get the genome-scale
landscape of transcriptional or post-transcriptional gene expression.
Now, RNA-Seq faces several technological challenges like other high-throughput
sequencing technology such as data storage capacity, process large amounts of data.
Therefore, these challenges should be overcome to reduce errors by removing low-quality
reads, improvement in base-calling. Despite the challenges, RNA-Seq has facilitated us to
make an unprecedented large-scale overview of the transcriptome. Keeping in mind, RNASeq revealed many novel transcribed regions, splicing isoform for many genes. In this thesis,
I have mainly focused on the pipeline which is appropriate for NGS data generated from the
Illumina platform. Additionally, I have also described the details analysis which I have
performed through the pipeline. Particularly, the approach of sequencing in the Illumina
machine comprises the following fundamental steps:
1) Informative RNA enrichment
An archetypal RNA-Seq experiment begins by purifying a subset of RNAs from the
total RNA to analysis of transcriptome expression. Particularly, for protein coding RNAs, this
enrichment analysis is carried out by selecting poly(A)+ molecules using oligo-dT associated
with magnetic or cellulose beads. It is worth mentioning that prokaryotic mRNAs, poly(A)transcripts in eukaryotic cells are frequently subject to exploration (Hrdlickova et al., 2017).
Additionally, in cells the most abundant RNA is rRNA, >90% present in cells consists on
rRNA (Wilhelm and Landry, 2009) and need to be depleted due to small interest in most
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studies (Tariq et al., 2011). Though, varieties of selection processes have been developed
recently for rRNA depletion, oligo-dT based purification of poly (A)+ RNA is the prime
method that ensures to get a strong signal for the RNA population of interest.
2) RNA fragmentation
Still now, RNA fragmentation is the most commonly used technique in RNA-Seq
library preparation. Before reverse transcription (RT) process, RNA samples are subjected to
fragmentation process to get a certain size range. This fragmentation process happened after
selection of poly (A)+ or rRNA depletion. Due to the limitations of the size, fragmentation
process is mandatory in the most sequencing platforms. After purification, the larger RNAs
are fragmented by using RNA hydrolysis or nebulisation. On the other hand, full length
double-stranded cDNA can be fragmented by DNaseI treatment or sonication. Now cDNA
fragmentation is more likely towards the 3′ end of the transcript.
3) Synthesis of double stranded cDNA
In RNA-Seq, sequencing of poly (A) RNAs is the most common application unless a
very small amount of RNA is accessible. In eukaryotes, most protein-coding RNAs contain
poly (A) tail. The RNA fragments are converted into cDNAs using reverse transcriptase
enzyme which requires the hybridization of primers into the RNA chain. These primers can
be oligo-dT or sequence of random primers. For most protein-coding RNAs (mRNAs) and
many long noncoding RNAs (lncRNAs), it is not advisable to use the oligo-dT primers due
it’s biasness on the 3′ of the transcript. As a result, the sequencing reads will be enriched for
the 3′ ends of the transcript (Wilhelm and Landry, 2009). Therefore, random primers are
preferred to use which have the potential hybridization capacity to random sites of the RNA
molecule. Finally, after synthesizing the first strand of cDNA, the RNA template is
eliminated and generated a second cDNA by using DNA pol I and finally a double stranded
cDNA molecule is generated. Therefore, poly (A) purification is a preferred method to select
poly(A) + RNA.
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4) Adapters ligation
In a benchmark of RNA-Seq library etiquette, a desired size of cDNAs has been generated
through reverse transcription (RT) of fragmented RNAs with random hexamer primers.
Before amplification and sequencing process, a required extent of cDNAs has been also
generated based on the fragmentation of full-length cDNAs that are ligated to DNA adapters.
During adapter ligation process, 3′ of the cDNA overhangs are switched into blunt ends by a
specialized enzyme. Next a series of 3′ ligations occurred by using a truncated RNA ligase II
whereas 5′ adapter ligation happened by using RNA ligase I (Hrdlickova et al., 2017). In
order for ligation, the cDNA fragments to the adapter, an A base is added to the 3′ depleted
end which contain a single T base over-hanged at their 3′ end. Finally, distinctive adapters are
ligated to each strand of 3′ ends of the double-ended cDNA.
5) Size selection and PCR amplification
During fragmentation step, DNA molecules are divided into two different sizes. By
gel extraction, a desired range of DNA length is purified to ensure that all molecules are of
similar length. Furthermore, this procedure eliminates unligated adapters as well as those
ligated to one another. Finally, two primers are annealed to the adaptors tail followed by
amplification by PCR of the purified cDNA.
6) Cluster generation
Inside the flow cell, single-stranded DNA templates are bridged-amplified to form
clonal clusters prior sequencing. During the PCR amplification, the double stranded
molecules need to be denatured into single strands molecules. Subsequently, by using the
high density of immobilized forward and reverse primers, the DNA templates are hybridized
to a slide. Now, DNA polymerase is used to copy the templates from the hybridized primers.
After the denaturation, the original templates disappear the copies immobilized on the flow
cell surface. After fixation process, the immobilized copies are hybridized to adjoining
primers. Then DNA polymerase copied the templates and finally formed double stranded
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DNA bridges which in turn are denatured and formed two single-stranded DNA templates.
Finally, using the base cleavage the reverse DNA strand is removed and the immobilized 3′ends of the forward strand are prohibited to prevent interference in the sequencing process.
This procedure is repeated to create a dense clonal cluster that contains at least 1000
molecules per cluster.
7) Sequencing-by-synthesis
High throughput sequencing has been started with the sequencing hybridization
primers which added each single-stranded molecule in the clusters. Then DNA-templates are
simultaneously reversing complemented by using fluorescent-labeled nucleotides. After
addition of nucleotide, clusters are excited by a laser which causes fluorescence at the last
integrated base. The cycle is repeated to remove the fluorescent dye and blocking group. The
cycle is generated a sequence of images, containing new incorporated nucleotide where the
fluorescence labeled signal of each cluster is captured. As a result, the color of the lighted
spot represents a different base type. Then a sequence of nucleotide for each cluster can be
obtained by combining the attaining the sequence of images. Finally, this information is
saved in a text file named as FASTQ file format. FASTQ file contains a unique ID to identify
the read, the sequence of nucleotides and the quality scores. Due to the ubiquitous nature in
illumina, FASTQ format has become de facto for NGS analysis. Now to understand the read
quality at each base is defined by the Phred score that can range from 0 to 60 on a logarithmic
scale. The Phred quality score is defined as Q=-10log(e).
NGS can read sequence from both ends of a single DNA and generate “pair-end
reads”. FASTQ files are always pre-processed to check the quality controls and remove any
adapters in the sample preparation process. Sometimes contamination can be detected by the
distribution of k-mers which help to detect the contamination. These all help to detect the
potential pitfalls before the downstream analysis.

19

3.3 Quality control of sequencing reads
Next-generation sequencing (NGS) technologies have drastically broaden the area of
genomic research. High-throughput sequencing technology can generate enormous amounts
of data in a single sequencing run. To extract biological conclusions by analyzing acquired
sequence, it is important to assess the library quality as well as the sequencing performance.
Therefore, for any alignment process, the low quality of reads should be removed (Levin et
al., 2010). Due to a range of artifacts generated during library preparation, NGS can be
adversely affected the downstream analyses.
Until recently, to highlight the quality score of the NGS data, several software tools
have been developed. Contamination with adapter sequences and biases in base composition
are the primary reason to generate the low-quality base (Trivedi et al., 2014). To assess the
quality of the raw reads generated by the sequencing platform is the foremost step of the
quality

control

(QC)

process

and

FastQC

(http://www.bioinformatics.babraham.ac.uk/projects/fastqc) is a popular tool for this analysis.
In NGS platform, FastQC is useful for considering the overall quality score of a sequencing
run and commonly used as an initial QC checkpoint. Given a set of raw sequencing reads, the
main aim of quality control (QC) is to align the reads to a reference genome and consider the
quality of the alignments. The quality of alignments can be obtained by several metrics such
as depth of coverage, contamination of rRNA, continuity of coverage, and GC bias
(Andrews, 2010). The main purpose of performing quality control is to process raw sequence
data coming from high throughput sequencing prior to aligning against a reference genome.
Now to evaluate the quality of the high throughput sequencing reads, some valuable
information needed to be extracted from the variation of the Phred quality score (Q score) of
a sequencing platform (Yang et al., 2013). The content of bases has very little difference
between different bases during sequencing. Now the number of bases added when the
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sequencer is unable to produce any base call with enough confidence of reads length (Ewing
et al., 1998).
Based on this type of analysis, the low sequencing quality bases should be eliminated
to ensure the quality of the high throughput data. From the high throughput sequencing, the
cellular activity is characterized and going to be extracted the biological conclusions.
3.4 Mapping reads
After removal of abnormal reads from the raw cDNA sequence reads, it is mandatory
for the short sequenced to be mapped to a reference genome or transcriptome. The main goal
of this step is to find the genomic location of each transcript sequence on a given reference
genome. According to Fonseca et al. this problem can be achieved by computationally
(Fonseca et al., 2001). This helps to match the reads with the reference genome and this can
be challenging because sequencing generated millions of short reads that needed to be
mapped to reference genomes that usually very large. So, it is important that mapping
algorithms needed to be extraordinarily competent and used processors and memory in a
most advantageous way. Moreover, 50% repetitive sequences present in complex organisms
such as human or mouse genome, so it is another challenging aspect in next-generation
sequencing that needed to be handled. Therefore, mapping tools are required to handle this
multiple mapping locations (Fonseca et al., 2001).
Spliced alignment

Exon A

Exon B

Exon A

(a) Alignment of a paired-end read to the
genome. The read needs to be mapped across
introns (spliced alignment)

Exon B

Exon C

(b) Alignment of a paired-end read to the
transcriptome

Figure 3.1. Mapping of a paired-end read with different reference files: genome and transcriptome. Adapted
from Trapnell and Salzberg, Figure 2 (2009).

Sometimes, aligning reads against the reference genome is slower because it considers
all non-coding positions. Currently, several alignment programs are available to handle
spliced alignments, including TopHat2 (Kim et al., 2013), SOAPSplice (Huang et al., 2011),
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Blat (Kent, 2002) or Exonerate (Slater and Birney, 2005). On the other hand, Bowtie 2
(Langmead and Salzberg, 2012), BWA (Li and Durbin, 2009), MAQ (Li et al., 2008) or
SOAP2 (Li et al., 2009) are specialized for aligning short reads to a reference genome.
In computational biology, Bowtie 2 is used as short-read mappers that can able to
index a file and speeded up the mapping process. This mapping process allows an efficient
and relatively small memory (Langmead and Salzberg, 2012). Particularly, Bowtie 2 indices
are based on the Burrows-Wheeler Transform (BWT) that helps to keep the memory low
(Kent, 2002). In human genome, this transformation keeps the memory to fit in 3.5 gigabytes.
The alignment process is extracted raw NGS read which are likely to be matched in the
genome with the Burrows-Wheeler Transform (BWT) based methodology (Burrows and
Wheeler, 1994). Finally, each aligned character slender the list of possible mapping or
genomic positions. Sometimes seed placement will be prioritized if Bowtie 2 cannot find a
location where the read align perfectly (Langmead and Salzberg, 2012). Using the Single
Instruction Multiple Data (SIMD)-accelerated dynamic programming algorithm, we can
check whether sufficient numbers of alignments are examined (Slater and Birney, 2005;
Trapnell and Salzberg, 2009; Langmead et al., 2009).
The output file from the mapping is a SAM format file. SAM file contains all the
information of overlapped and non-overlapped reads. Particularly, overlapped reads contains
the information about the genome location where the read was mapped and it’s respective
score (Li et al., 2009).
3.5 Expression quantification and normalization
During mapping of the RNA-Seq reads, it’s needed to convert the data into a
quantitative measure of gene expression. Several approaches are available now-a-days, but in
this problem, the easiest approach is adding up the number of reads which lie within the
location of each element (Van Verk et al., 2013; Wilhelm and Landry, 2009). It is easy to
extract this information if reads were overlapped to the transcriptome otherwise gene
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expression measurement can be performed by using Cufflinks package if reads were aligned
to the genome (Trapnell et al., 2012). In RNA-Seq, estimation of gene/transcript expression is
predominantly relying on the no. of reads that aligned to each transcript sequence. There are
several algorithms available recently for transcript/gene mapping. One such algorithm known
as Sailfish that mainly depends on the on k-mer read counting without the need for mapping
(Conesa et al., 2016). However, gene expression measurement can be quantified by using
HTSeq package that enable aligned reads to the genome (Anders et al., 2015). This
quantification process uses GTF file that contains genome coordinates of exons and genes.
Now to compare the expression levels among samples, transcript length, and total number of
reads affect read count.
Read A

Read B
TopHat

Mapped
Reads

Mapped
Reads
Cufflinks

Annotated
Transcripts

Annotated
Transcripts

Cuffmerge
Final
Transcripts
Assembly
Mapped
Read

Cuffdiff

Mapped
Read

Differential
gene
expression
CummeRbund

Expression plots

Fig 3.2. An overview of the tuxedo protocol. The assembly and characterization of expressed genes
from the experimental data, statistical analysis of differential gene expression. QC study is performed in
the raw RNA-Seq reads using FastQC; the filtered reads are then mapped to a reference file using
Bowtie 2; from this data is measured the gene expression level and performed a differential expression
test by Cuffdiff; the genes are then concatenated into GO terms using GOStats. In the end, this will give
insight into the biological processes that are differentially active between the conditions in comparison.
Adapted from Trapnell et al., Figure 2 (2012).

To remove this biasness, RPKM (reads per kilobase of exon model per million reads)
normalizes a transcript’s read by both its length and the total number of reads mapped in the
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sample to remove the feature-length and library-size effects. FPKM (fragments per kilobase
of exon model per million mapped reads) normalized paired-end data (Mortazavi et al.,
2008). During the RNA-Seq experiment, two conditions will be examined where reads are
first mapped to the genome with TopHat. These mapped reads are fed to Cufflinks, which
produces one file of assembled transfrags for each replicate. Finally, Cuffdiff analysis
performed to get the differential gene expression analysis. These files are visualized with
CummeRbund to facilitate exploration of genes identified by Cuffdiff as differentially
expressed, spliced, or transcriptionally regulated genes as it can be seen in figure 3.5.
To estimate transcript-level expression several sophisticated algorithms have been
developed recently. Cufflinks approximate transcript level expression from a genome
mapping by using a TopHat. Cufflinks use GTF information to identify differentially
expressed transcripts. RSEM (RNA-Seq by Expectation Maximization) (Li and Dewey,
2011), eXpress (Forster et al., 2013) algorithms have been used to normalize within the
sample to correct the sequencing biasness which quantify the expression from transcriptome
(Finotello et al., 2014).
3.6 Differential expression
After quantification and normalization, statistical testing usually performed between
conditions. Due to count-based nature of RNA-Seq data, Poisson distribution provides a good
fit for counts arising from technical replicates, has been performed (Marioni et al., 2008).
According to Leek et al. (Langmead et al., 2010) and Smyth et al. (Robinson and Smyth,
2007) these distributions do not account for biological variability across samples. Because
Poisson’s distribution accounts for the variance which is associated with the biological
replicates and will be prone to high false discovery rate (FDR). FDR arises from the
underestimation of sampling error (Robinson and Smyth, 2008). To overcome this limitation,
recently many methods were developed that measure the statistical significance in a dataset
with a low number of biological replicates. Cuffdiff finds differentially expressed genes and
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transcripts that are transcriptionally and post-transcriptionally regulated and groups
transcripts into biologically meaningful groups (Trapnell et al., 2012). In Cuffdiff, it is
assuming that the number of reads produced by each transcript is proportional to its
abundance (Trapnell et al., 2012). In RNA-Seq, presence of large number of technical
variabilities arises during library preparation and in the same experiment, variation of
biological replicates sometimes fluctuates changes in expression. Even though it’s
exceptional level of accuracy, RNA-Seq has sources of bias during the gene expression
analysis. However, Cuffdiff can automatically eliminate a large fraction of the bias in RNASeq read distribution across each transcript and improves its abundance estimates. RNA-Seq
has less technical variance compared to micro-arrays (Zhao et al., 2014). During sequencing,
Cuffdiff provided multiple technical or biological replicate in sequencing libraries per
condition and will help how read counts vary for each gene across the replicates. These
variances calculate the significance of observed changes in expression (Trapnell et al., 2012).
In cuffdiff, user can fed two or more SAM/BAM files, generated from TopHat alignment, as
well as a GTF file that contains transcript annotations as input. As an output file, Cuffdiff
reports numerous files that contain the results of DEG analysis. User can download and can
be viewed with any spreadsheet application (such as Microsoft Excel). These files contain
fold change in log2 scale, P values, q value and gene/transcript name and location in the
genome (Trapnell et al., 2012). During differential gene expression analysis, Cuffdiff identify
genes that are differentially spliced or regulated via promoter switching. In a gene, Cuffdiff
groups together isoforms that have the same TSS which are all derived from the same premRNA. Cuffdiff also calculates the total expression level of a TSS group by summing up the
expression levels of the isoforms. Due to the presence multiple TSSs in a gene, Cuffdiff is
also looking for changes in expression between TSS in different conditions.
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3.7 Pathway analysis
Being a knowledge-driven quality, biologists are facing everyday how to interpret large-scale
data especially with the emergence of high-throughput technology. The limitation usually lies
to understand the meaning of array of genes to divulge the underlying molecular mechanism
of the phenotype. Finally, list of differentially expressed genes can be grouped into common
pathways; enable to identify differentially expressed pathways. The purpose of this pathway
enrichment analysis is to find ultimate possibilities of the hidden connections of molecular
information (transcriptome) with the phenotype of an organism in study (Emmert-Streib and
Glazko, 2011). For individual genes, the variation in gene expression depends upon a certain
disease that could be only moderate or even negligible. The pathway enrichment analysis of
set of genes variation can evidence differences between different phenotypes (Mootha et al.,
2003) and evaluates the function of differentially expressed genes and executes different
cellular pathways and this pathway knowledge available in public repositories such as the
Gene Ontology (GO) (Ashburner et al., 2000) and the Kyoto Encyclopedia of Genes and
Genomes (KEGG) (Kanehisa et al., 2012). The pathway information concatenates into these
databases with the gene expression patterns, resulting in the transformation of the array of
individual gene identification into these pathways. According to Khatri et al. pathway
analysis is performed based on overrepresentation analysis (ORA) and usually provided as an
input a preselected differential expressed gene list (Khatri et al., 2012; Huang et al., 2009).
This preselected list of genes will be taken from the output of cuffdiff analysis which has
with higher rates of under- or over-expression with a certain FDR. A test is executed to
ensure if the lists of gene have any biological function in general also involved in the same
cellular process (Trapnell et al., 2009). The most commonly used tests are Fisher’s exact test
(Evangelou et al., 2012), hypergeometric (Zeeberg et al., 2003), chi-square (Falcon, and
Gentleman, 2007), or binomial distribution. An extensive list of tools that are designed to
perform this type of analysis is introduced by Lempick et al. (Zhong et al., 2004).
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CHAPTER 4
METHODS
4.1. Tailor pipeline:
Over the past few years, ample amounts of methods had been developed to deal with different
aspects of RNA-Seq data analysis. However, it was required to combine several bespoke
methods to address the needs and specificities of each problem and sometimes this
combination is not a simple challenge. Therefore, special awareness must be taken to prevent
erroneous biological conclusions.
With these considerations in mind, we proposed a sequence of tools (pipeline) which
is suitable to perform a comparative study between RNA-Seq samples. The pipeline referred
as “Tailor Pipeline” which can able to able to take from raw RNA-Seq reads, to extract the
main biological processes differing between the analyzed conditions as it can be seen in
figure 4.1.

Figure 4.1. Schematic representation of the Tailor_Pipeline used in the RNA-Seq data. The raw
.Bcl file has been submitted in the GHPCC cluster and performed differential gene expression analysis
by using TopHat, Cufflinks, and Cuffdiff. Gene set enrichment analysis performed to identify the
differentially regulated BPs, CCs and MFs and visualize the most differentially expressed pathways.

The pipeline has a broad interest because sometimes biologists interested to perform a
comparative analysis, on the bench, under different environments, cells are treated with
different pathogenic agents. Frequently, the best-chosen approach is the sequencing of the
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cell transcriptome by using high-throughput sequencing, next-generation sequencing
techniques (Shendure and Ji, 2008). However, the next-generation technologies generated,
routinely, a dozen of gigabytes of data. Now, to extract relevant biological information from
it, the computational power is essential. For that reason, this pipeline will provide all the
necessary information which is required to solve any biological problem. The details result of
this pipeline described in the subsequent chapters of this thesis.
A diagram illustrating the conceived pipeline is showed in Figure 4.1. This pipeline
was implemented in a Tailor_file and incorporates both publicly available tools and scripts
developed by Riley lab group members to perform the biological evaluation of the RNA-Seq
data.
Data analysis begins with the input of the raw read files and the reference files. Once
this data is gathered, reads are processed with FastQC (Trapnell 2004). FastQC consists of
Java software which provides tools to perform a QC study in raw high throughput sequencing
data. The analysis performed by this tool ensures that the data is qualitatively good and there
are no problems or biases in it and reported per base sequence quality, per sequence quality
scores, per base sequence content, per base GC content, per base N content, sequence length
distribution, sequence duplication levels, overrepresented sequences and Kmer content.
Sometimes, sequencer and the starting library materials may create some problem which can
be easily detected by a QC analysis. Some abnormalities may be resolved by trimming base
pairs from the raw read. The pipeline contains a script that can trim a given number of base
pairs during this analysis. The pipeline is pre-set not to trim any bases from the raw
nucleotide sequence. However, this option can be modified in the Tailor_file, depending on
the QC results.
Afterwards, trimming, reads will be aligned with a reference sequence using Bowtie
2, a well-established mapper (Langmead and Salzberg, 2012). In RNA-Sequencing
technology Bowtie2 is a fast and memory-efficient mapping tool that is particularly suitable
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for the alignment of small reads, to the respected genome reference. In our analysis we have
used the human and mouse genome respectively. Previously to the mapping process, the
reference file must be indexed to be used by Bowtie2. To perform this task, bowtie2-build is
used. This tool constructs a Bowtie index from the set of DNA sequences in the reference
file, which usually is in the FASTA format (Langmead 2010). Once the index is built, Bowtie
no longer uses the original FASTA sequence. At this point, a set of options associated with
the type of search performed by the Bowtie 2 algorithm need to be defined. The output of the
mapping process is a Sequence Alignment/Map (SAM) file which stores the information
about the read alignments against the reference sequence. Particularly, for paired-end reads
two records are printed (i.e. two lines of output) describing the mapping proprieties for each
comparison (Li 2009).
Typically, after mapping RNA-Seq reads to a reference genome, the number of reads
that map a certain gene or transcript is measured. The read counts have been found to be
roughly linearly related to the abundance of the target transcript (Mortazavi 2008). To get the
gene expression information, the pipeline uses TopHat, a script integrated in the TopHat
package that counts how many reads map to a certain feature (Kim 2013). Due to the nature
of this study, where high-level pathway enrichment analysis was the goal, it was not relevant
to consider multiple isoforms of the same gene. To perform the count of the mapping reads, a
reference genome file is required that contains information about the features.
Next differential expression analysis was performed between the RNA-Seq samples to
detect differentially expressed genes among the conditions in study and differential gene
expression analysis has been done by using Cuffdiff (Trapnell 2012), that takes the output
files from TopHat or another read aligner. This output files are two or more fragment
alignment SAM/BAM files, as well as a merged.gtf from the output of Cuffmerge as input
(Trapnell 2012). Cuffdiff tests the observed log fold change in transcripts expression against
the null hypothesis of no change and produces several output files for changes in expression
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at the transcript level, primary transcripts, and genes. To use multiple conditions, users must
specify multiple replicates by feeding in the associated BAM files for each condition. For
each gene, the output table contains information about the mean gene expression level, the
fold change from the first to the second condition, the logarithm (to basis 2) of the fold
change, the p-value for statistical significance of this change and the p-value adjusted with
Benjamini-Hochberg procedure (Benjamini and Hochberg, 1995) that controls the percentage
of false positives among all the rejected hypotheses (FDR).
To select the significant differentially expressed genes, the algorithm is pre-set to
perform a trimming based on the raw output table by selecting only p-value less than 0.1. To
understand this trimming, it was necessary to have a clear knowledge about which statistical
measure the p-value translates provided the null hypothesis is true. This null hypothesis refers
to a general or default position and it was rejected if the p-value is less than a significance
level. In differential gene expression analysis, the null hypothesis corresponds to a scenario in
which the genes were not significantly differentially expressed. This means that lower pvalues was unlikely that the observed difference was occurring randomly and, thereby, the
0.1 p-value cut-off assures that only the statistically important entries will be considered for
further analysis.
Lastly, the genes found to be differentially expressed are associated with GO terms
using a Bioconductor package called GOStats (Gentleman and Falcon, 2013). GOStats used a
hypergeometric test to relate a given gene list with the standardized controlled vocabulary in
the GO database. Particularly, it consists in three structured controlled vocabularies:
biological processes (BP), sets of molecular events which are essential to the functioning of
integrated living units; cellular components (CC), parts of cells or its extracellular
environment; and molecular functions (MF), elemental activities of a gene product at
molecular level (Ashburner 2000). In the final step, it is possible to have a biological insight
about the samples being compared. Based on the output table user can able to conclude the
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most significantly differentially expressed active processes when the cell is subjected to
different biological conditions. To perform an analysis using the Hypergeometric-based test
implemented in the GOStats package, the pre-set universe is contained a genome wide
annotation database for Homo sapiens, mouse and others those are mapped with Entrez Gene
identifiers. The pipeline is adjusted to analyze any species RNA-Seq data. Secondly, it is
necessary to define a list of genes for the analysis and this list corresponds to the collection of
genes in the final table of the differential expression analysis step. For the entries generated
through the hypergeometric test, it is defined a p-value cut-off of 0.1. Additionally, the test
direction is set as over, so the result of this step will be a table with the over represented GO
terms associated with the differentially expressed genes found in the previous pipeline step
for each one of the ontologies. In other words, GOStats will identify most important ontology
terms that differ between the conditions being compared in the cuffdiff analysis.
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CHAPTER 5
RESULTS
Part-1: Diet induced SAMP6 mice results
5.1. Dataset Description
In this study SAMP6 strain mouse were used and colonies taken from eight females
and four males. For 25 mice each SAMP6 and AKR/J were fed with high fat diet (HFD).
Generally, the age of those mice is 6–8 weeks of age. High-fat diet contains fat, protein, and
carbohydrates and low-fat diet (LFD) contains fat, protein, and carbohydrates. In HFD, 60%
calories are coming from fat whereas in LFD, 10.2% calories are coming from fat. This
feeding process continues for 6 months where mice were fed daily with fresh high, low-fat.
Subsequently Mice were sacrificed, and RNA has been extracted by using TRIZOL reagent.
Then, two treated, HFD and LFD, SAMP6 mice were used in biological triplicates for library
preparation. All RNA samples are DNAse treated and used to create single indexed (6 base
pairs) RNA-Seq libraries by using TruSeq RNA preparation kit according to the
manufacturer’s protocol [96]. All sequencing has been done by using the Illumina HiSeqTM
2500 instrument. HiSeqTM 2500 was used to sequence RNA-Seq libraries that have been
loaded with software version 3. Then performed 51-cycle paired-end run of the single
indexed RNA-Seq libraries and demultiplexing has been done by using the raw bcl base call
files upon completion. Based on that RNA-Seq dataset has been created from SAMP6
background strain mice that were fed regular low-fat and high diet (Table-5.1).
High fat mice

Low fat mice

NK001_1_CGATGT

NK004_4_GCCAAT

NK002_2_TGACCA

NK005_5_CAGATC

NK003_3_ACAGTG

NK006_6_CCTGTA

Table 5.1. Data set of diet induced mice study. The experimental data is composed 3 biological replicates for
each of the 2 different conditions. 3 high fat and 3 low-fat diet mice were used for this experiment.
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The Tailor pipeline was used to process the experimental data characterized above. In the
subsequent section I have described the results from each processing step, interpret them and
ultimately, conclude about which are the up- and down- regulated pathways in diet induced
SAMP6 mice that associated with fibrosis.
5.2. Differential Gene Expression
Overall, the quality of the HF-SAMP6-over-LF-SAMP6 RNA-Seq data was high.
Nevertheless, the quality modules would generate warnings. Those inadvertences appeared
on per base sequence content, on the per base GC content and on the Sequence Duplication
levels sections. Particularly, the first warning topic plots out the proportion of the four DNA
bases for each base position in a sequence file. These properties were not verified for any of
the analyzed read files. In fact, all of them had a high variability on the first 15 bases, which
pointed out to the presence of an overrepresented sequence in the library. This may be related
with a problem in the library generation or can be a consequence of an abnormal sequencing
process. However, the most plausible explanation was the use of random hexamer priming to
introduce biases at the start of sequencing reads, as described by Hansen et al., 2010 (Hansen
2010). Based on this study, 15 bases were trimmed from the beginning of each original
sequence. Given that the reads are long (90 base pairs); the loss of information inherent with
this trimming is not significant. Therefore, each one of the reads is composed, after this step,
by 75 base pairs.
The filtered HF-SAMP6-over-LF-SAMP6 reads were then mapped against a
reference mouse genome (mm10) file. The reference file was downloaded from Ensemble
website and contains the reference mouse DNA sequence in FASTA format. The reference
file was indexed by bowtie-build and used by Bowtie 2 to perform the mapping of the HFSAMP6-over-LF-SAMP6 RNA-Seq reads to the reference mouse genome. Following
alignment of the RNA-Seq reads, the data need to be translated into a quantitative measure of
gene expression. This task can be achieved by TopHat, which counts the number of reads that
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map a given gene. To perform this, it is necessary a reference file that contains all the
annotated protein coding and non-coding genes in the mouse genome release 10. This
information is contained on a GTF file that was downloaded from Ensemble’s website
(ftp://ftp.ensembl.org/pub/release-71/gtf/homo sapiens/Homo sapiens.GRCh37.71.gtf.gz).
After running TopHat, the output file fed into Cuffquant to compute gene and
transcript expression profiles and saves these profiles such that it can be analyzed in a timely
manner by Cuffdiff which the last step is to determine differential gene expression (DGE).
Cuffquant take the .bam mapping files made from each of the 6 biological replicates along
with the merged.gtf file and generate .cxb (compressed binary file). Cuffquant reduces the
computational load of quantifying gene and transcript expression of the HF-SAMP6-over-LFSAMP6 sample especially if there are more than a handful of libraries.
Given the samples and the respective conditions that constitute the diet induced
SAMP6 mice dataset, it was decided to compare SAMP6 HFD-fed to LFD-fed mice samples.
Cuffdiff is a program that uses the cufflinks transcript quantification engine used to test the
observed log fold change in its expression against the null hypothesis of no change and find
differentially regulated genes and transcripts at the transcriptional and post-transcriptional
level that share a common transcription start site.
The Cuffdiff module takes two or more fragment alignment BAM files from TopHat
(such as accepted_hits.bam), as well as a reference GTF file containing transcript annotations
as input. To do so, each one of the outputs from the previous step was concatenated with the
table containing the information about the gene expression level in the control sample. From
these concatenated tables, Cuffdiff estimates the dispersion of each gene and analyses
whether there is differential expression between the defined conditions (e.g. comparison
between SAMP6 HFD-fed compare to LFD-fed mice). The final throughput of this step is a
table in which the entries correspond to the genes that are significantly differentially
expressed among the two conditions being compared.
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Our analysis included a total of 23,285 differentially expressed genes including
protein coding transcripts and non-coding transcripts, lncRNAs, and microRNA from the
SAMP6 HFD-fed compare to LFD-fed mice. Of these 387 genes were significantly
differentially expressed between High fat and Low-fat diet mice according to the cut-off
criteria (P<0.05 and |log2FC| >1.5). Now Cuffdiff result output is very large and is not
possible to visualize the data. So, we have used CummeRbund to simplify the analysis and
visualize the output of a differential expression analysis by using cuffdiff. CummeRbund
handles the transformation of Cuffdiff data into the R statistical computing environment,
making RNA-Seq expression analysis with Cuffdiff more compatible with many other
advanced statistical analyses and plotting packages. CummeRbund takes the output files from
cuffdiff and creates an SQLite database which describes the relationships between genes,
transcripts, transcription start sites, and CDS regions.
This data can be represented in an MDS-plot, illustrates the pattern of similarities or
distances among a set of objects (Figure-5.1). More specifically, each dot in the MDS-plot
corresponds to a gene. In the x-axis in the plot represents the first euclidean dimension, and
the y-axis the second euclidean dimension.
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Figure 5.1. A multidimensional scaling (MDS) plot of the merged gene expression
data. MDS-plots for all the high fat and the low fat diet induced to the SAMP6 mice.
The figure shows a perfect separation between high fat SAMP6 and low fat SAMP6
mice. All color coded by biological replicates, with different symbols corresponding to
different replicates.

Euclidean distances can be placed in a several ways. These distances can be placed in
multidimensions but the standard way of representing MDS is to just plot the Euclidean
distances with x-axis being Dimension 1 and y-axis being Dimension 2. The dimensions are
ordered based on how well samples are separated. Figure-3.2 is represented the MDS-plots
for all the high fat and the low-fat diet induced to the SAMP6 mice. The closer the labels are
together, the more similar the samples are. So, it is good to see that the high fat diet samples
are clearly separated from the low-fat diet treated samples. In addition to this, genes classified
as significantly differentially expressed with an FDR less than 0.1 in high fat and the low-fat
diet induced to the SAMP6 mice are also clearly separated. By visually comparing the MDSplots of diet induced SAMP6 mice samples lead us to check another dimension reduction
technique such as Principal Component Analysis. It minimizes the dimensions and preserves
the covariance of data whereas MDS minimizes dimensions, preserves distance between data
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points. Figure-5.2 is represented the PCA-plot that shows a perfect separation between highfat and low-fat diet biological replicates. In this method, the samples data points are projected
onto the 2D plane in such a way so that data points are spread out in the two directions. This
explain most well separation in the datapoints in the two-dimensional space. In the MDS plot,
the x-axis is the direction that shows the maximum variation in the data point and is
written PC1. The y-axis is orthogonal to the first direction which separates the data point
second most in this direction and is written PC2. The percentage of total variance is
demonstrated in the axis label which shows maximum variation.

Figure 5.2. Principal component analysis. The PCA analysis was
based on the gene expression patterns in high fat (HF) and low fat
(LF) SAMP6 mice with induction of different diet. Analysis showed
a perfect separation between two different diets. In the figure,
LF_SAMP6_1 overlapped with LF_SAMP6_2.

However, it is important to keep always in mind that this analysis was performed with any
number of biological replicates. In fact, as stated before, it is important to note that the
biological conclusions extracted from the described methodologies must be interpreted with
care. In fact, differences in library construction and variability intrinsic to the biological
samples can greatly influence the number of false positives. It is imperative to have
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biological replicates in the RNA-Seq dataset since these are essential in the measurement of
the sample’s intrinsic variability. Therefore, the absence of replicates is reducing the power
of DE inference among RNA-Seq samples. After performing this analysis, we have decided
to perform an additional layer of analysis that enables to see the functions of those
differentially expressed genes.
5.3. Gene Ontology enrichment – GOStats
Using the pre-set options defined in the tailor pipeline, GOStats identified the
statistically significant ontology terms that differ between SAMP6 HFD-fed compare to
LFD-fed mice. In the following subsections a summary of the obtained results is described
and compared with what it was expected, having into account that urinary voiding
dysfunction was more severe in SAMP6 and was associated with pronounced prostatic and
urethral tissue fibrosis. The X-axis represent the –log10 (p-value) and the Y-axis represent the
biological, cellular or the molecular processes.
5.3. A Biological Processes:
SAMP6 HFD-fed compare to LFD-fed mice analysis provided significant ontologies that
described operations or sets of molecular events pertinent to the functioning of fibrosis that
are associated with diet induced high fat mice. In all, 13 biological processes were highly
over-represented in our gene list, with p-values < 0.05 and fold-enrichment values of >2-fold
(Table - 5.2).
Table – 5.2 Summary of the BP ontology terms and respective p-value associated with the set
of differentially expressed genes from SAMP6 HFD-fed compare to the LFD-fed analysis.
GOBPID
GO:0009605
GO:0009611
GO:0001907
GO:0032571
GO:0044004
GO:0051919

Odds Ratio
Inf
45.863
1836.556
1836.556
1836.556
1836.556

Term
response to external stimulus
response to wounding
killing by symbiont of host cells
response to vitamin K
disruption by symbiont of host cell
positive regulation of fibrinolysis
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-log10(P-value)
3
3
3
3
3
3

GO:0007598
GO:0065008
GO:0016485
GO:0080134
GO:0051604
GO:0017187
GO:0018214

1377.333
Inf
51.987
32.604
48.202
500.636
500.636

GO:0051818

500.636

GO:0051883

500.636

GO:0006508
GO:0006828

28.997
458.889

GO:0010640

458.889

GO:0051917

458.889

GO:0006957

393.286

GO:0007597
GO:0031639
GO:0030194
GO:0050927
GO:1900048
GO:0050926
GO:0050820
GO:0007596
GO:0042730
GO:0007599
GO:0050817
GO:0030449
GO:0018200
GO:0019835
GO:0031640
GO:0044364
GO:2000257

305.815
275.2
239.261
239.261
239.261
229.278
220.093
28.787
211.615
28.521
28.521
196.476
189.69
189.69
189.69
189.69
183.356

blood coagulation, extrinsic pathway
regulation of biological quality
protein processing
regulation of response to stress
protein maturation
peptidyl-glutamic acid carboxylation
protein carboxylation
disruption of cells of other organism
involved in symbiotic interaction
killing of cells in other organism involved
in symbiotic interaction
Proteolysis
manganese ion transport
regulation of platelet-derived growth factor
receptor signaling pathway
regulation of fibrinolysis
complement activation, alternative
pathway
blood coagulation, intrinsic pathway
plasminogen activation
positive regulation of blood coagulation
positive regulation of positive chemotaxis
positive regulation of hemostasis
regulation of positive chemotaxis
positive regulation of coagulation
blood coagulation
Fibrinolysis
Hemostasis
Coagulation
regulation of complement activation
peptidyl-glutamic acid modification
Cytolysis
killing of cells of other organism
disruption of cells of other organism
regulation of protein activation cascade

3
2.69897
2.69897
2.69897
2.69897
2.522879
2.522879
2.522879
2.522879
2.522879
2.522879
2.522879
2.522879
2.39794
2.30103
2.30103
2.221849
2.221849
2.221849
2.221849
2.221849
2.221849
2.154902
2.154902
2.154902
2.154902
2.154902
2.154902
2.154902
2.154902
2.154902

The differential biological processes analysis shows that “GO:0007598”, “GO:0017187” and
“GO:0051818” are top most over-represented. The associated processes are blood
coagulation, extrinsic pathway, peptidyl-glutamic acid carboxylation and disruption of cells
of other organism involved in symbiotic interaction.
SAMP6 HFD-fed compare to LFD-fed mice has led us to provide deregulation of
wound healing response, coagulation is responsible for the tissue fibrosis. Over the last
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decade, coagulation signaling coordinate inflammation and tissue repair through the
generation of fibrin and activation of proteinase-activated receptors (PARs) (Kryczka and
Boncela, 2017). Coagulation cascade promote hemostasis and limit blood loss in response to
tissue injury which will help to promote tissue fibrosis. Therefore, targeting the PARs will be
a potential approach to limit fibrosis.
From this evaluation it is possible to conclude that the main differences between
SAMP6 HFD-fed compare to LFD-fed mice is high fat diet induced SAMP6 mice associated
with blood coagulation, extrinsic pathway which is a key factor for the tissue fibrinolysis
which is concomitant to tissue fibrosis in high fat diet mice.
5.3. B Cellular Components:
Cellular components ontology associated with parts of a cell or its extracellular environment.
Comparing SAMP6 HFD-fed to LFD-fed analysis, “GO:0005579” and “GO:0005615” were
over-represented cellular components (Table - 5.3).
Table - 5.3 Summary of the CC ontology terms and respective p-value associated with the set
of differentially expressed genes from SAMP6 HFD-fed compare to the LFD-fed analysis.
GOCCID
GO:0005615
GO:0005579
GO:0046930
GO:0005886

Odds Ratio
37.326
986.167
369.604
Inf

Cellular Components
extracellular space
membrane attack complex
pore complex
plasma membrane

-log10(P-value)
2.69897
2.69897
2.39794
2.221849

The associated terms were membrane attack complex and extracellular space. The –log10 (PValue) is highly enriched for the term “membrane attack complex”. Remembering that BP
“blood coagulation” is highly overrepresented for the SAMP6 HFD-fed compare to the LFDfed analysis. But in the case of cellular components, membrane attack complex is highly over
represented. Evidence suggested that formation of membrane attack complex direct
associated with accumulation of fibrosis and complement activation may be responsible for
the profibrotic response that occurs in the tubulointerstitial compartment (Abe 2004).
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Stimulation of proximal tubular epithelial cells with membrane attack complex increased the
mRNA concentrations of collagen type IV and its intracellular chaperone such as Heat Shock
Protein 47 (HSP47).
5.3.C Molecular Functions:
The significant MF were described the elemental activities of a gene product at the molecular
level. Only one GO term is associated with the molecular function in this analysis. The GO
term “GO: 0004252” is associated with serine-type endopeptidase activity (Table - 5.4).
Table - 5.4 Summary of the MF ontology terms and respective p-value associated with the set
of differentially expressed genes from SAMP6 HFD-fed compare to the LFD-fed mice
analysis.
GOMFID
GO:0070679
GO:0004175
GO:0015279

Odds Ratio
1038.000
76.749
830.300

GO:0070011

55.297

GO:0008233

53.387

Molecular Functions
inositol 1,4,5 trisphosphate binding
endopeptidase activity
store-operated calcium channel activity
peptidase activity, acting on L-amino
acid peptides
peptidase activity

-log10(P-value)
2.69897
2.69897
2.69897
2.39794
2.39794

In has been reported, protease may target many substrates which activate cell migration and
fibrosis which support statistically (Kryczka and Boncela, 2017). Furthermore, serine-type
endopeptidase activity is also described to be related with the mesenchymal transition and
fibrosis. On the other hand, this activity term evidences the regulation of cell junction
decomposition and ECM degradation. This may help to liberate sequestered growth factors
such as TGFβ or VEGF that increases leukocytes infiltration and prolong inflammation.
Finally, these proteases target many substrates and thus inflicting changes in distinct
biological processes which correlated with cell migration and fibrosis (Kryczka and Boncela,
2017).
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5.4. Pathway Analysis:
Finally, the list of differentially expressed genes can be grouped into common pathways. This
analysis identifies differentially active pathways and, ultimately, possibilities the connection
of molecular information (transcriptome) with the SAMP6 HFD-fed compare to the LFD-fed
mice analysis. Gene Ontology analysis reveals high fat diet SAMP6 mice involved in blood
coagulation process which plays pivotal roles in orchestrating inflammatory response. In
addition to this high fat diet SAMP6 mice engaged in membrane attack complex which is
directly associated with accumulation of fibrosis. This insinuates us to check the significant
pathway which may associate with fibrosis.
Tailor pipeline identified 39 significantly differentially expressed pathways. Pathway
enrichment analysis evaluates the significantly differentially expressed genes that concatenate
into cellular pathways. The Kyoto Encyclopedia of Genes and Genomes (KEGG) is a public
repository that contains pathway information (Kanehisa 2012). This is performed by relating
the pathway information into these databases with the gene expression patterns, resulting in
the transformation of the list of individual genes into a set of pathways. Previously report
suggested up-regulation of a pre-fibrotic pathway namely the “ECM-Receptor Interaction”
has been associated with fibrosis (Ekstedt 2006).
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Figure 5.3. KEGG pathway of mm10 illustration of ECM receptor pathway. ECM
receptor interaction showed differential expression of specific genes in this pathway.
Genes significantly up-regulated consequent to high fat diet treatment in red, up-regulated
consequent to low fat diet treatment in green, not differentially expressed in gray
(arbitrary scale indicates extent of differential expression).

The ECM plays a central role to maintain the normal function of different tissues. It has been
widely comprehended, over-expression of extracellular matrix (ECM) proteins have been
associated with fibrosis (Almanza, D., 2018). In our analysis it can be shown collagen is upregulated which presumably participates in the development of tissue fibrosis (Figure-5.3).
Though diet induced SAMP6 mice did not show any fibrotic livers, may be this pathway
insinuate the early stage of tumorigenesis. Apart from the extra cellular matrix pathway we
have observed an unusual pathway known as the “peroxisome proliferator-activated receptor
pathway” is highly over-expressed in our analysis (Figure-5.4).
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription
factors of nuclear hormone receptor super family composed of three members namely PPARα, PPAR-δ, and PPAR-γ and play an essential role in metabolism by heterodimerization with
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the retinoid X receptor (RXR) that bind to the specific regions on the DNA of the target
genes. From the signaling pathway it can be visualized that PPAR-γ is targeted many genes
such as ME1, ACBP, FABP1, LPL, ACO, CYP4A1, Thiolase B. Their main function is to
promote lipogenesis, cholesterol metabolism, fatty acid transport, fatty acid oxidation. Due to
down regulation of PPAR-γ in SAMP6 HFD-fed compare to the LFD-fed mice analysis, all
the downstream target genes become down expressed and will not be able to transport fatty
acid. Finally, oxidation of fatty acid and the metabolism of cholesterol become inhibited.
Now chronic imbalances in lipid metabolism are often associated with obesity, Type-2
diabetes (T2D) and chronic liver disease. The common cause of chronic liver disease is the
nonalcoholic fatty liver disease (NAFLD) disease which is responsible to accumulate the
white adipose tissue in the liver (Ekstedt 2006). In this analysis we can visualize that
oxidation of fatty acids are down regulated, suggested us to speculate that blood levels of
triglycerides and free fatty acids are chronically elevated and excess fatty acids are derived
from the extracellular source such as diet. Finally, it is reported that in liver, chronically
elevated fat deposits result in NAFLD, which can lead to steatohepatitis (NASH) and,
eventually, to non-reversible hepatic cirrhosis (Ekstedt 2006).
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Figure 5.4. KEGG pathway of mm10 illustration of peroxisome proliferator-activated receptor
(PPAR) pathway. PPAR pathway showed differential expression of specific genes in this pathway.
Genes significantly up-regulated consequent to high fat diet treatment in red, up-regulated consequent to
low fat diet treatment in green, not differentially expressed in gray (arbitrary scale indicates extent of
differential expression).

It has been reported that NAFLD can develop a worst prognosis like cirrhosis and
hepatocellular carcinoma (Yu 2016). In hepatocellular carcinoma, several different
biomarkers have documented recently, and our aim is to find any of these known biomarkers
are presented in our diet induced mice samples. After performing differential gene expression
analysis by cuffdiff, we have identified genes/transcripts that are significantly differentially
expressed in hepatocellular carcinoma. It is worth mentioning that several growth factors
such as EGF1, EGF2 are upregulated in our diet induced SAMP6 mice model system and we
are suspecting these may provide a pre-malignant signature. Because, EGFR plays an
important role in cell growth and concurrently lead to the development of transformation by
increasing the transcriptional activity. However, this premalignant signature has been
implicated in cancer considering this may play an important role for uncontrolled cell growth
and proliferation which is a characteristic feature of cancer (Grandhi 2016).
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Part-II. Stromal Fibroblast Cell line results
5.5. Dataset Description
In this analysis N1 cells were used and these cells were derived from a stromal
fibroblast cell line. These cells were expressed fibroblastic markers such as vimentin and
calponin. These cells were demonstrated proliferation and secretion profiles which was
somewhat similar with aging primary prostate fibroblasts (Rodríguez-Nieves 2016).
Fibroblast cells were treated with human CXCL12 and human TGFβ and Trizol is used to
extract RNA. Isolated RNA from N1 cells treated with CXCl12 or TGFβ were used to
prepare libraries. All RNA samples are DNAse treated and used to create single indexed (6
base pairs) RNA-Seq libraries by using TruSeq RNA preparation kit according to the
manufacturer’s protocol. All sequencing has been done by using the Illumina HiSeqTM 2500
instrument. HiSeqTM 2500 was used to sequence RNA-Seq libraries that have been loaded
with software version 3. Then performed 51-cycle paired-end run of the single indexed RNASeq libraries and demultiplexing has been done by using the raw bcl base call files upon
completion. The experimental data is composed 3 biological replicates for each of the 2
different conditions mentioned such as CXCL12-vs-Control, TGFβ- vs- Control, and
CXCL12-vs-TGFβ.
5.6. Differential Gene Expression
The pipeline described above was used to process the experimental data characterized above.
In the subsequent section results from each processing step, interpretation and ultimately,
conclusion has been made to decipher which are the up- and down- regulated pathways in
CXCL12-vs-TGFβ induced fibroblast to myofibroblast phenoconversion. The .Bcl basecall
files generated by Illumina HiSeq2500 were converted to FASTQ format using
Tailor_Pipeline. This conversion was done with the help of bcl2fastq tool. To generate a
single FASTQ file for each biological replicate, we have used the default parameter that split
the files after 4 million reads to the reference human genome. This alignment file will be used
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in the further downstream analysis of the stromal fibroblast data. In this analysis we have
mainly focused on the Cuffdiff that enables to perform the differential gene expression
analysis for the quantification of the transcripts for the samples. In computational biology it’s
important to know the function the genes/transcripts which is differentially expressed in the
sample and gene ontology analysis is the prime important for this field and we have used
GOStats R package to analyze the result considering that we have kept p-value of ≤0.05. In
cell line data analysis, we have considered the pathview package that associated with the
enrichment analysis. This enrichment analysis used to elucidate and visualized the top upregulated cellular pathways, or down-regulated in CXCL12, or TGFβ treated cells by
considering the cutoff q value ≤0.05. Transcriptomics analysis using human N1 cells which
were derived from a stromal fibroblast demonstrated secretion and proliferation profile which
was consistent with aging primary prostate fibroblasts (Patalano 2018). Moreover, RNA-Seq
analysis of stromal fibroblast data revealed total of 10,633 transcripts were induced by
CXCL12 or TGFβ compared to controls.
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These studies utilized human N1 cells which were derived from a stromal nodule of benign
prostatic hyperplasia, exhibit a fibroblastic morphology, and demonstrate secretion and
proliferation profiles consistent with aging primary prostate fibroblasts. Analysis of RNASeq data revealed that a total of 10,633 transcripts were induced by CXCL12 and TGFβ
compared to vehicle controls. Of these, 9378 (82.5%) transcripts were significantly
differentially expressed by CXCL12 and TGFβ, 734 (6.5%) were differently expressed
consequent to TGFβ treatment only, 1255 (11%) by CXCL12 treatment only as it can be seen
in figure 5.5.
Recent transcriptomics analysis reveals an astounding number of non-coding RNAs
(ncRNAs) present in human genome. These ncRNAs have lack the capacity to code for a
protein. Therefore, to date, these ncRNAs are as a “dark matter” and “junks” of human
genome. Yet, over the past decade, several studies have shown these ncRNAs have numeral
biological functions. However, it is still in debate, whether, ncRNAs transcription reflects
accurate biology or offshoot of a leaky transcriptional system. Now, it is a broad question
how we can able to interpret the biological meaning of transcription that distinguishes a gene
that is simply transcribed.
Depending on the type of ncRNAs, transcription can occur by incorporating three
RNA polymerases namely RNA Pol I, RNA Pol II and RNA Pol III. ncRNAs can be
classified into two categories such as small ncRNAs and long ncRNAs depending upon the
size. Recently, long noncoding RNAs (lncRNAs) are emerging aspect of modern biology,
especially their role in human diseases have come into our attention. Many lncRNAs with
tumor-suppressor or oncogenic functions in cancer have been discovered. However, genomewide transcriptomics study mediated by high-throughput sequencing technique has
revolutionized the genomics study and the pipeline identified lncRNAs that are significantly
differentially expressed in stromal fibroblast cell line and have their role in tissue fibrosis.
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We used RNA-Seq dataset that was acquired from N1 cells treated with CXCL12 or
TGFβ. The experimental data is composed 3 biological replicates for each of the 2 different
conditions. The datasets were sequenced by using paired-end sequencing on an illumina
Hiseq-2500.
5.7. Prediction of fibrosis associated lncRNAs:
In this study, transcripts were reconstructed by using the genome guided methods.
Current transcriptomics study falls into two categories based on the availability of genome:
genome-guided and genome independent de-novo assembly (Garber et al., 2011). Also, we
have determined the coding potential of lincRNAs was proposed in this study. First, TopHat
was used to map the RNA-Seq reads in each sample to the human GRCh38 reference genome
and 85.9% of the total RNA-Seq reads in each sample have been successfully mapped to the
reference genome. Then, Cufflinks was subsequently used to assemble these aligned reads
into transcripts based on the known gene annotation (Trapnell 2004), and the assembled
transcripts were annotated and grouped into different categories using the Cuffcompare
program from the Cufflinks package.
The fundamental aim of differential expression analysis is to identify genes that
change in abundance between different experimental conditions. In this study, we used
Cuffdiff (a module in Cufflinks package), to detect significantly differentially expressed
lncRNAs between the CXCL12-vs-TGFβ induced stromal fibroblast tissues (Trapnell 2012),
where the false discovery rate (FDR) was set to be 0.05.
High-throughput sequencing followed by bioinformatics analysis is a main stream of
detecting the lncRNA. They have recently gained an attention due to their widespread
involvement in disease. Based on the differentially expressed lncRNAs, we have performed
cluster analysis to see the variation of expression between CXCL12 and TGFβ compared to
control as it can be seen in figure 5.6.
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From the analysis the expression levels of the significantly differentially expressed lncRNAs
have altered. Based on that, we have identified lncRNAs namely MALAT1, NEAT1, TUG1,
PTENP1, Kcnq1ot1, DNM3OS, Scarb2, SRSF9, SNHG16, FADS1, WRAP53, HEIH, HEIH,
HOTAIRM1, SNHG11, DMPK, PVT1, MAP3K14, SNHG3, SRA1, GAS5, TERC that were
upregulated in our analysis. Of these differentially expressed lncRNAs, we have observed 7
lncRNAs namely MALAT1, NEAT1, TUG1, PTENP1, Kcnq1ot1, DNM3OS and Scarb2 are
upregulated in both CXCL12 and TGFβ induced N1 cell line. MALAT1 involved promoting
tumor growth and metastasis and regulate alternative splicing and cell cycle regulation that
may associated with Prostate cancer (Cheetham 2013). MALAT1 increased HCC cell
migration; tumor metastasis and recurrence through Wnt/TCF/β-catenin and Hippo/yesassociated protein (YAP) signaling pathways (Nordin et al 2014; Wang et al. 2014). NEAT1
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has proven to be a transcriptional regulator for numerous genes; few of them are involved in
liver and prostate cancer progression and promoted cell proliferation and invasion
(Chakravarty 2014). TUG1 has also been suggested to be significantly associated with
hepatocellular carcinoma and promoted cell growth and apoptosis (Mehra and Chauhan
2017). Finally, PTENP1 is a highly homologous processed pseudogene of the tumor
suppressor gene PTEN that itself exerts a tumor suppressive function by acting as a decoy for
PTEN targeting miRNAs (Poliseno 2010). Chen et al, reported the main function of PTENP1
is to repress tumorigenic properties of HCC. The role of lncRNA potassium voltage‑gated
channel subfamily Q member 1 opposite strand/antisense transcript 1 (KCNQ1OT1) is
remain elusive in the context of myofibroblast phenoconversion. It is transcribed from intron
10 of the maternally expressed Kncq1 (KvLQT1) gene from a CpG island that is the
imprinting control region (IC2) (Smilinich 1999). It has been reported that lncKCNQ1OT1
has been associated with diverse array of functions. Of these, one of the most important
function is the involvement of cell proliferation. Because KCNQ1OT1 promotes cell
proliferation through the upregulation of SMAD4 which is upregulated in both CXCL12 and
TGFβ treated cell line. Previously, it was reported that TGFβ promotes the myofibroblast
phenoconversion through SMAD dependent pathway. Furthermore, the results indicated that
an increase level of KCNQ1OT1 may correspondingly regulate SMAD4 expression levels.
So, we may suspect the lncRNA KCNQ1OT1 may promote fibroblast to myofibroblast
phenoconversion through SMAD dependent pathway. DNM3OS, a gene that is transcribed
into a non-coding RNA (ncRNA), contains three micro RNAs (miRNAs), miR-199a, miR199a*, and miR-214, whose functions remain unknown. It has been reported the long noncoding RNA DNM3OS as a critical downstream effector of TGF-β-induced myofibroblast
activation via SMAD dependent pathway. However, in the context of stromal fibroblast cell
line, it remains unknown their function and the mechanism through which they promote
myofibroblast phenoconversion. Hence, it may provide a novel paradigm for the treatment of
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fibrosis. Finally, the function of lncRNA Scarb2 in cell proliferation is still elusive and need
to be further investigated. The differentially expressed lncRNAs have been documented in
the table 5.5.
Table 5.5:

Gene Name

Location

CXCL12 treated-vs control

TGFβ treated-vs control

Fold change

Q-Value

Fold change

Q-Value

MALAT1

11q13.1

1.995986551

0.000074448

2.229654234

0.000081672

NEAT1

11q13.1

1.568616847

0.000074448

1.686939226

0.000081672

TUG1

22q12.2

2.635305103

0.000074448

2.894210791

0.000081672

PTENP1

9p13.3

1.390510848

0.0040057

1.922231374

0.000081672

Kcnq1ot1

11p15.5

2.31493229

0.0000820

2.2448359

0.0000885787

DNM3OS

1q24.3

1.92294833

Scarb2

4q21.1

1.6579724

SRSF9

12q24.31

SNHG16

0.0000820508 2.458008662
0.0000820

0.0000885787

1.888684862

0.0000885787

0.571988878

0.0000820508 0.596421843

0.0000885787

17q25.1

0.780392598

0.0000820508 0.635598665

0.0000885787

FADS1

11q12.2

0.828545597

WRAP53

17p13.1

0.59680023

0.0000820508 0.464709164

0.0000885787

HEIH

5q35.3

0.540972064

0.0000820508 0.629099011

0.0000885787

HOTAIRM1

7p15.2

0.606565774

0.0000820508

0.67005666

0.000258076

SNHG11

20q11.23

0.70463791

0.000315805

0.738212463

0.00183138

DMPK

19q13.32

0.623637679

0.0000820508

0.78306013

0.0000885787

PVT1

8q24.21

0.669973065

0.0000820508 0.532798897

0.0000885787

MAP3K14

17q21.31

0.671974783214

0.00120927

1.076055134

0.0032499

SNHG3

1p35.3

0.653230926

0.00120927

0.531131868

0.0327341

SRA1

5q31.3

0.604459674

0.0452502

0.637077592

0.0000820508 0.610607832
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0.00017404

0.0000885787

GAS5

1q25.1

0.73045991

0.0000820508 0.691657636

0.0000885787

TERC

3q26.2

0.412029631

0.0000820508 0.563245583

0.0000885787

In CXCL12 treated cell, COL1A1 and smooth muscle α-actin (αSMA) is upregulated but not
TGFβ treatment. It’s an open area of research whether silencing of MALAT1 reduces the
mRNA levels of smooth muscle α-actin (α-SMA) and collagen type I, α1. However, to the
best of our knowledge, there have been no published studies to demonstrate the specificity of
these genes in fibroblast tissue. Thus, the results of this study can open a new theoretic
insight into the identification of fibrosis specific genes.
5.8. Prediction of fibrosis associated miRNAs:
Identification of lncRNA by using the Tailor pipeline, our next question is whether any other
short noncoding RNA that may differentially expressed to promote myofibroblast
phenoconversion. Specially, microRNAs (miRNAs), play a crucial role in tumorigenesis and
attenuates TGF-β signaling to stimulate angiogenesis and tumor growth (Bartel 2009; Suzuki
and Miyazono 2011). They also play a significant role in tumor suppression in cancers
(Hwang and Mendell 2006). Thus, we may hypothesize that miRNAs might be the important
regulators to proliferate cancer cell and to promote myofibroblast phenoconversion.
By RNA-Seq, we found 9 miRNAs namely miR100HG, miR143HG, miR17HG,
miR210HG, miR22HG, miR4435-2HG, miR663A, miR663AHG and miR-let7BHG that had
significantly differentially expressed based on q-value < 0.05 and considering they may have
a role in promoting myofibroblast phenoconversion. Our bioinformatics analysis revealed
differentially expressed miRNAs, we have performed cluster analysis to see the variation of
expression between CXCL12 and TGFβ compared to control as it can be seen in figure 5.6.
From the hierarchical analysis it can be revealed miRNAs expression have been altered. Of
note, the two most upregulated miRNAs are miR100HG and miR22HG (Fig. 5.7) that may
interest in this analysis and assuming their possible role is to promote myofibroblast
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phenoconversion. Though it’s suspected but not validated yet their positive role in
myofibroblast phenoconversion. The detailed list of miRNAs has been documented in the
table 5.6. MIR100HG is a polycistronic miRNA host gene, which encodes miR-100, let-7a-2,
and miR-125b-1 within its third intron, involved in cell proliferation and differentiation
(Emmrich et al., 2014). Previous reports showed that miRNAs played an essential role in
fibrosis, while the mechanism was not clear and needed

more elucidation. The detailed information of upregulated miRNAs is documented in table
5.6. Furthermore, over-expression of miR-100HG and miR-22HG in this stromal fibroblast
cell line upon inducing the TGFβ highlighting a miRNA-mediated regulatory network
potentially important for cellular proliferation.
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Table 5.6:

Gene Name

Control
(FPKM
value)

MIR100HG

5.97311

CXCL12
treated –vs
control
(FPKM
value)
14.3705

MIR143HG

1.74695

0.776572

MIR17HG

3.634215

MIR210HG

TGFβ
treated -vs
control
(FPKM
value)
17.3948

Fold Change

Q-Value

2.66289118

0.00007806

1.13852

0.549678074

0.01771129

2.72922

2.48242

0.716698003

0.00099742

5.14924

2.57128

4.27341

0.667055105

0.00813042

MIR22HG

9.454085

11.4505

14.5692

1.378657307

0.00306516

MIR4435-2HG

130.665

96.4805

86.2446

0.698804625

0.00007806

MIR663A

35614.05

11488.3

16110.3

0.388444969

0.00007806

MIR663AHG

88.0577

33.4411

55.4406

0.506454721

0.00007806

MIRLET7BHG

3.408655

2.1428

2.26701

0.647233958

0.00007806

However, Recent data suggested miR22HG upregulated and located in 17p13.3, a
chromosomal region that is frequently deleted, hypermethylated in hepatocellular carcinoma
[Zhang et al., 2018]. Previously, it was reported that miR22HG expressed significantly lower
in HCC and an associated with the prognosis of patients with HCC. In the contrary, in our
work we have noticed a significant increase in the expression of miR22HG and presumably it
may promote myofibroblast phenoconversion.
5.8. Revisit of aminoacyl tRNA synthetase
Genes of ARS being housekeeping, for long their connection to diseases remained
unsuspected. Their expressions vary dynamically from cell line to cell line and under stress
conditions. Besides their major canonical role in translation, they are involved in pathways of
cell signaling, cell survival, metabolisms of amino acids, stress response programs,
regulations of enzyme synthesis and apoptosis. Many consider them to be hotspots of the
regulation system (Ibba, M. & Söll, D. 2001).
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In human there are 37 ARS genes, distinguished into two distinct sets based on their
locations, either in cytoplasm (designated with single letter amino acid code followed by RS)
or in mitochondria (has a ‘2’ suffix). There are 17 cytoplasmic ARS (including the
bifunctional glutamyl-prolyl-tRNA synthetase, EPRS, in charge for aminoacylation of
tRNAGlu and tRNAPro), 18 mitochondrial, and 2 dual-localized, GARS and KARS, present
in cytoplasm as well as in mitochondria (Yao, P. & Fox, P. L. 2013).
Mammalian ARS interacts with multifunctional proteins (AIMPs) by catalyzing the ligation
of amino acids to their cognate tRNAs. Along with catalytic activity domains, ARS has other
motifs to interact with diverse regulatory factors. These structural convolutions are linked to
functional flexibility, notably to oncogenic pathways of apoptosis, angiogenesis, cell growth,
cell proliferation, signal transduction and many more (Park, S. G. et al.,2008). The deviations
of ARS/ARS2 gene expressions presumably meet the differential protein needs of cancer
cells, driving the malignancy.
To observe the common transcription profile of the ARS/ARS2 genes, we performed a largescale RNA-seq analysis on all the considered datasets. RNA-Seq analysis of stromal
fibroblast cell line, using 37 ARS/ARS2 gene expression signatures clearly pointed to the
differential expression of ARS/ARS2 genes. Following different quality control and
normalization procedures, differentially expressed genes (DEGs) were identified initially
using a fold change cutoff of >2. The differential expressions of ARS/ARS2 in leukemia
were visualized from the clusterogram, Fig. 5.8.
Observation of large-scale alteration of ARS/ARS2 gene-expressions indicated that enhanced
statistical analysis needed to be applied to identify more robust and reliable signatures. We
integrated different statistical approaches to achieve superior result. P values of genes were
calculated across samples to identify gene expression signatures that differentiated cancer
tissues from normal tissues. Further, we computed FDR (False Discover Rate), to sharpen the
significance of our result. Our RNA-Seq analysis, based on q-value (FDR test), showed that
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IARS, IARS2, EPRS, LARS, NARS, TARS, WARS2, in stromal fibroblast cell line, were
upregulated. To verify these anomalous expressions, we have seen that two AARS/AARS2
namely NARS and WARS2 are upregulated in both the CXCL12 and TGFβ induced
fibroblast cell line.

As we observed varied rates of differentiation of ARS/ARS2 genes, it was assumed they took
part in biological processes and molecular functions other than just in translation. Hence, we
performed gene ontology (GO) analysis to determine the distribution of ARS/ARS2 genes in
cell, the biological processes they took part in and the molecular functions they performed.
From GO database we figured the precise scattering of ARS/ARS2 in and around a cell.
Interestingly, they were not only restricted to cytosol and mitochondria but also dispersed in
their surroundings. Remarkably, NARS, have the potential to promote tumor metastasis and
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growth and WARS2 was involved in angiogenesis followed by migration and proliferation.
Though what that implies functionally, still needs to be interpreted.
5.9. Gene Ontology Analysis
After performing the differential gene expression analysis, our next aim is to perform the
gene ontology analysis to see any significantly upregulated ontology that was associated with
the fibroblast to myofibroblast phenoconversion. Based on that in our developed tool, we
used some condition in the gene ontology step to get the over represented GO-terms. In
overrepresented GO terms, if the condition becomes TRUE, the hypergeometric test
performed by using the conditional algorithm to estimate for each biological term whether
they are statistically overrepresented at the specified p-value cutoff where it finds all child
terms are significant. Calculation of log odds ratio (LR) revealed GO biological process
(table 5.7) was profoundly weighted towards DNA synthesis in the TGFβ-mediated treatment
whereas this was less evident in the CXCL12-mediated signature, where protein synthesis,
protein metabolism, protein modification and ER to Golgi vesicle-mediated transport are
more prominent.
Table – 5.7 Summary of the BP ontology terms and respective p-value associated with the set
of differentially expressed genes from CXCL12-over-control analysis.
GOBPID
GO:0000183
GO:1990542
GO:0007080

Odds Ratio
24.82936394
19.06785988
18.45824575

GO:0051204

16.14479465

GO:0032508

15.8948578

GO:1903747

14.45812097

GO:1900740

14.41086604

GO:1901522

14.41086604

Term
chromatin silencing at rDNA
mitochondrial transmembrane transport
mitotic metaphase plate congression
protein insertion into mitochondrial
membrane
DNA duplex unwinding
regulation of establishment of protein
localization to mitochondrion
positive regulation of protein insertion
into mitochondrial membrane involved
in apoptotic signaling pathway
positive regulation of transcription from
RNA polymerase II promoter involved
in cellular response to chemical stimulus
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-log10(p-value)
7.274905479
5.411168274
5.217527376
4.480172006
8.517126416
3.943095149
3.931814138

3.931814138

GO:0051436

13.31509217

GO:0008625

13.29756425

GO:0060444

13.25546539

GO:0010972

12.67793051

GO:0006418

12.41262554

GO:0006302

11.90967462

GO:0006120

11.83303051

GO:0006595
GO:0007004
GO:0031571
GO:0019068

11.52319145
11.52319145
10.41741799
10.38302752

GO:0043153

10.36889313

GO:0006415
GO:0033044
GO:0000097
GO:0006895
GO:0006995

10.02806271
9.897565234
9.791909169
9.791909169
9.791909169

GO:0032981

9.791909169

GO:0043984

9.791909169

GO:0072401

9.689339469

GO:0006399

9.492567568

GO:0072413

9.39830346

GO:1902402

9.39830346

GO:2001020

9.289625916

GO:0006361

9.227594114

GO:0009226
GO:0046755

9.215035299
9.215035299

GO:0050687

9.215035299

GO:1902590

9.215035299

GO:1902400

9.107379013

GO:0006900
GO:0043038

8.959219858
8.660193246

negative regulation of ubiquitin-protein
ligase activity involved in mitotic cell
cycle
extrinsic apoptotic signaling pathway via
death domain receptors
branching involved in mammary gland
duct morphogenesis
negative regulation of G2/M transition
of mitotic cell cycle
tRNA aminoacylation for protein
translation
double-strand break repair
mitochondrial electron transport, NADH
to ubiquinone
polyamine metabolic process
telomere maintenance via telomerase
mitotic G1 DNA damage checkpoint
virion assembly
entrainment of circadian clock by
photoperiod
translational termination
regulation of chromosome organization
sulfur amino acid biosynthetic process
Golgi to endosome transport
cellular response to nitrogen starvation
mitochondrial respiratory chain complex
I assembly
histone H4-K16 acetylation
signal transduction involved in DNA
integrity checkpoint
tRNA metabolic process
signal transduction involved in mitotic
cell cycle checkpoint
signal transduction involved in mitotic
DNA damage checkpoint
regulation of response to DNA damage
stimulus
transcription initiation from RNA
polymerase I promoter
nucleotide-sugar biosynthetic process
viral budding
negative regulation of defense response
to virus
multi-organism organelle organization
intracellular signal transduction involved
in G1 DNA damage checkpoint
membrane budding
amino acid activation
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6.896196279
3.580044252
3.568636236
3.388276692
6.341988603
6.022733788
5.982966661
3.029653124
3.029653124
9.838631998
2.677987561
2.674484337
11.56703071
2.524910197
2.498393078
2.498393078
2.498393078
2.498393078
2.498393078
8.966576245
6.649751982
8.617982957
8.617982957
4.431798276
4.401209493
2.32339783
2.32339783
2.32339783
2.32339783
8.272458743
4.238072162
5.91721463

GO:1900101

8.647345302

GO:0007096
GO:0008535

8.638271487
8.638271487

GO:0010664

8.638271487

GO:0042772

8.638271487

GO:0048194

8.638271487

GO:0051571

8.638271487

GO:0051788
GO:0060055

8.638271487
8.638271487

GO:0006614

8.369598373

GO:0006363

8.360110803

GO:0000184

8.128249567

GO:0002042

8.071060172

GO:0072599

7.981565268

GO:0006413
GO:0000723
GO:0007569
GO:0034644

7.963422108
7.918843642
7.807743979
7.799597855

GO:0048199

7.78206475

GO:2000785

7.78206475

GO:0051437

7.750186943

GO:0006414
GO:0019083
GO:0070124
GO:0070125
GO:0050434
GO:0006298
GO:0033014
GO:0072583

7.678671896
7.586166812
7.525527831
7.525527831
7.509285851
7.493124523
7.493124523
7.493124523

GO:1901028

7.308158062

GO:2001022

7.217753519

GO:0000722
GO:0046685

7.204239473
7.204239473

regulation of endoplasmic reticulum
unfolded protein response
regulation of exit from mitosis
respiratory chain complex IV assembly
negative regulation of striated muscle
cell apoptotic process
DNA damage response, signal
transduction resulting in transcription
Golgi vesicle budding
positive regulation of histone H3-K4
methylation
response to misfolded protein
angiogenesis involved in wound healing
SRP-dependent cotranslational protein
targeting to membrane
termination of RNA polymerase I
transcription
nuclear-transcribed mRNA catabolic
process, nonsense-mediated decay
cell migration involved in sprouting
angiogenesis
establishment of protein localization to
endoplasmic reticulum
translational initiation
telomere maintenance
cell aging
cellular response to UV
vesicle targeting, to, from or within
Golgi
regulation of autophagosome assembly
positive regulation of ubiquitin-protein
ligase activity involved in regulation of
mitotic cell cycle transition
translational elongation
viral transcription
mitochondrial translational initiation
mitochondrial translational elongation
positive regulation of viral transcription
mismatch repair
tetrapyrrole biosynthetic process
clathrin-mediated endocytosis
regulation of mitochondrial outer
membrane permeabilization involved in
apoptotic signaling pathway
positive regulation of response to DNA
damage stimulus
telomere maintenance via recombination
response to arsenic-containing substance
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2.151995729
2.149721447
2.149721447
2.149721447
2.149721447
2.149721447
2.149721447
2.149721447
2.149721447
12.55284197
3.886056648
13.69250396
3.714442691
13.35457773
11.69680394
5.258060922
3.557520231
6.73754891
3.54515514
3.54515514
8.230622674
11.13489603
12.42945706
9.381951903
9.381951903
6.402304814
3.375717904
3.375717904
3.375717904
4.732828272
3.214670165
3.208309351
3.208309351

GO:0061615

7.204239473

GO:0061621 7.204239473
GO:1904292 7.204239473
GO:0051188 6.943963027
On the other hand, cellular

glycolytic process through fructose-63.208309351
phosphate
canonical glycolysis
3.208309351
regulation of ERAD pathway
3.208309351
cofactor biosynthetic process
3.055517328
component exhibited respiratory chain complexes, protein

synthesis and degradation, and cell division were predominant in the TGFβ-mediated
signature, whereas cellular signaling and Cul4-RING E3 ubiquitin ligase complex, clathrin
vesicle coat, ECM component binding were prevalent in the CXCL12-mediated signature
(table 5.8).
Table - 5.8 Summaries of the CC ontology terms and respective p-value associated with the
set of differentially expressed genes from CXCL12-over-control analysis.
GOCCID
GO:0080008

Odds Ratio
14.94099

GO:0055029

13.77231

GO:0030125
GO:0005680
GO:0000502
GO:0030904
GO:0005838
GO:0022625
GO:0015934
GO:0034719
GO:0005685
GO:0070469
GO:0032040
GO:0005762
GO:0034045
GO:0030117
GO:0030014
GO:0005849
GO:0042645
GO:0030140
GO:0022627
GO:0005876
GO:0005689
GO:0030686
GO:0000313
GO:0000784

13.69341
13.06978
12.81038
12.44627
12.44627
11.23328
10.01159
9.953378
9.953378
9.368798
9.341876
9.341876
9.330439
8.749517
8.707614
8.707614
8.101777
8.09333
7.684893
7.483634
7.469399
6.845697
6.659933
6.45774

Term
Cul4-RING E3 ubiquitin ligase complex
nuclear DNA-directed RNA polymerase
complex
clathrin vesicle coat
anaphase-promoting complex
proteasome complex
retromer complex
proteasome regulatory particle
cytosolic large ribosomal subunit
large ribosomal subunit
SMN-Sm protein complex
U1 snRNP
respiratory chain
small-subunit processome
mitochondrial large ribosomal subunit
pre-autophagosomal structure membrane
membrane coat
CCR4-NOT complex
mRNA cleavage factor complex
mitochondrial nucleoid
trans-Golgi network transport vesicle
cytosolic small ribosomal subunit
spindle microtubule
U12-type spliceosomal complex
90S preribosome
organellar ribosome
nuclear chromosome, telomeric region
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-log10(p-value)
4.031517
3.664996
3.645314
3.453179
6.473661
3.26184
3.26184
8.095284
4.785156
2.506006
2.506006
2.329249
4.393619
4.393619
2.319935
5.88941
2.135281
2.135281
5.329754
3.664145
4.970616
6.261219
3.305304
2.951187
7.767004
7.431798

GO:0005801
GO:1902555
GO:0030137
GO:1990391
GO:0036452
GO:0005839
GO:0000159
GO:0016604
GO:0030529
GO:0098803
GO:0032154
GO:0071339
GO:0098687
GO:0016592
GO:0044452
GO:0015935
GO:0043601
GO:0031519
GO:1990234
GO:0005763
GO:0030880
GO:0010494
GO:0070603
GO:0005840
GO:0030660
GO:0097546
GO:0032993
GO:0035097
GO:0005925
GO:0005657
GO:0030055
GO:0032153
GO:0005654
GO:0000118
GO:0005730
GO:0000151

5.919117
5.910571
5.910571
5.602764
5.598976
5.598976
5.598976
5.066767
5.02695
4.99055
4.9847
4.978867
4.949023
4.825659
4.811433
4.78507
4.770978
4.734597
4.649523
4.563127
4.549874
4.5135
4.507754
4.37867
4.36177
4.355314
4.309986
4.29852
4.216674
4.209384
4.143092
4.095622
4.072825
3.974436
3.841616
3.797252

GO:0016591

3.793665

GO:0016607
GO:0012507
GO:0016363
GO:0005901
GO:0070013
GO:0005643
GO:0031974

3.744944
3.736606
3.703721
3.687077
3.674888
3.617216
3.598013

cis-Golgi network
endoribonuclease complex
COPI-coated vesicle
DNA repair complex
ESCRT complex
proteasome core complex
protein phosphatase type 2A complex
nuclear body
ribonucleoprotein complex
respiratory chain complex
cleavage furrow
MLL1 complex
chromosomal region
mediator complex
nucleolar part
small ribosomal subunit
nuclear replisome
PcG protein complex
transferase complex
mitochondrial small ribosomal subunit
RNA polymerase complex
cytoplasmic stress granule
SWI/SNF superfamily-type complex
Ribosome
Golgi-associated vesicle membrane
ciliary base
protein-DNA complex
histone methyltransferase complex
focal adhesion
replication fork
cell-substrate junction
cell division site
Nucleoplasm
histone deacetylase complex
Nucleolus
ubiquitin ligase complex
DNA-directed RNA polymerase II,
holoenzyme
nuclear speck
ER to Golgi transport vesicle membrane
nuclear matrix
Caveola
intracellular organelle lumen
nuclear pore
membrane-enclosed lumen
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4.524329
2.430589
2.430589
3.234427
2.260372
2.260372
2.260372
3.602025
16.29158
5.847712
4.308035
2.73702
9.453457
3.366154
5.527244
2.583606
2.574413
3.985908
10.45469
2.413596
10.1707
3.046508
6.262013
11.86646
4.127844
2.254707
5.228413
5.79588
28.15677
5.037631
28.29073
4.277366
183.6421
4.583359
49.5867
15.45469
6.9914
12.49349
3.216913
6.69897
5.35164
207.567
4.754487
222.266

GO:0031463
GO:0005819
GO:0097525
GO:0044424
GO:0016605
GO:0030496
GO:0000922
GO:0072686
GO:0005813
GO:0098798
GO:0000228
GO:0005778
GO:0005912
GO:1902554
GO:0005741
GO:0000788
GO:0008305
GO:0005759
GO:0000785
GO:0000777

3.577708
3.49422
3.490056
3.486763
3.479006
3.409893
3.390406
3.348538
3.274238
3.26026
3.186168
3.184547
3.175634
3.173936
3.130656
3.112128
3.111162
3.088013
3.046311
3.043233

GO:0032592

3.035933

GO:0031902
GO:0005694
GO:0008180
GO:0005782
GO:0005740
GO:0000786
GO:0031201
GO:0005776
GO:0030027
GO:0005905
GO:0005881
GO:0031965
GO:0005623
GO:0019867
GO:1903293
GO:0005637
GO:0005765
GO:0000792
GO:0045121
GO:0044438
GO:0001726

2.948891
2.932461
2.904121
2.904121
2.899519
2.862159
2.8371
2.829458
2.818115
2.804605
2.803116
2.80047
2.777139
2.772263
2.767649
2.767649
2.738271
2.733042
2.70816
2.660447
2.625921

Cul3-RING ubiquitin ligase complex
Spindle
spliceosomal snRNP complex
intracellular part
PML body
Midbody
spindle pole
mitotic spindle
Centrosome
mitochondrial protein complex
nuclear chromosome
peroxisomal membrane
adherens junction
serine/threonine protein kinase complex
mitochondrial outer membrane
nuclear nucleosome
integrin complex
mitochondrial matrix
Chromatin
condensed chromosome kinetochore
integral component of mitochondrial
membrane
late endosome membrane
Chromosome
COP9 signalosome
peroxisomal matrix
mitochondrial envelope
Nucleosome
SNARE complex
Autophagosome
Lamellipodium
coated pit
cytoplasmic microtubule
nuclear membrane
Cell
outer membrane
phosphatase complex
nuclear inner membrane
lysosomal membrane
Heterochromatin
membrane raft
microbody part
Ruffle
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2.127909
6.39794
2.461535
2.911095
5.982967
7.954677
7.510042
3.418038
20.87615
2.195246
25.06198
3.456195
24.30892
4.08302
8.247184
2.360233
2.032217
16.54363
4.928118
5.228413
2.867686
5.44855
12.46344
2.089693
2.089693
30.49214
3.610763
2.789035
3.780958
7.818156
3.470975
2.97492
10.00305
97.72584
8.223299
2.660285
2.660285
11.24642
3.527382
11.17783
3.768717
3.664777

Molecular function analysis revealed that CXCL12 and TGFβ related genes encoded proteins
involved in DNA/RNA synthesis and regulation; protein synthesis and degradation and
ubiquitination (table 5.9).
Table – 5.9 Summary of the MF ontology terms and respective p-value associated with the
set of differentially expressed genes from CXCL12-over-control analysis.
GOMFID

Odds Ratio

GO:0034593

10.951

GO:0070064
GO:0008175
GO:0017025
GO:0019787

10.373
9.796
9.796
8.769

GO:0008353

8.642

GO:0010485
GO:0004709
GO:0004298
GO:0004708
GO:0019200

8.642
7.207
5.474
5.474
5.186

GO:0016538

4.804

GO:0051721

4.804

GO:0004712

4.618

GO:0008200
GO:0031369
GO:0051539
GO:0017048
GO:0043022

4.614
4.419
4.038
3.93
3.806

GO:0016896

3.747

GO:0031492
GO:0019213
GO:0008536
GO:0061631

3.747
3.691
3.458
3.458

GO:0003755

3.364

GO:0016627

3.234

GO:0050681
GO:0019003

3.172
3.101

GO:0030374

3.029

Term
phosphatidylinositol bisphosphate
phosphatase activity
proline-rich region binding
tRNA methyltransferase activity
TBP-class protein binding
ubiquitin-like protein transferase activity
RNA polymerase II carboxy-terminal
domain kinase activity
H4 histone acetyltransferase activity
MAP kinase kinase kinase activity
threonine-type endopeptidase activity
MAP kinase kinase activity
carbohydrate kinase activity
cyclin-dependent protein serine/threonine
kinase regulator activity
protein phosphatase 2A binding
protein serine/threonine/tyrosine kinase
activity
ion channel inhibitor activity
translation initiation factor binding
4 iron, 4 sulfur cluster binding
Rho GTPase binding
ribosome binding
exoribonuclease activity, producing 5'phosphomonoesters
nucleosomal DNA binding
deacetylase activity
Ran GTPase binding
ubiquitin conjugating enzyme activity
peptidyl-prolyl cis-trans isomerase
activity
oxidoreductase activity, acting on the
CH-CH group of donors
androgen receptor binding
GDP binding
ligand-dependent nuclear receptor
transcription coactivator activity
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-log10(p-value)
3
2.69897
2.522879
2.522879
2.154902
2.154902
2.154902
3
2.221849
2.221849
2.09691
2.69897
2.69897
2.522879
3
2.30103
3
3
3
2.30103
2.30103
2.69897
2.045757
2.045757
2.69897
2.221849
2.522879
3
3

GO:0019900
GO:0008094
GO:0048365
GO:0005080
GO:0003727
GO:0004860

2.785
2.748
2.718
2.628
2.623
2.623

GO:0004722

2.356

GO:0019903

2.349

GO:0001104

2.278

GO:0061733

2.211

GO:0043566
GO:0017137
GO:0003729
GO:0002020

2.2
2.181
2.068
2.009

kinase binding
DNA-dependent ATPase activity
Rac GTPase binding
protein kinase C binding
single-stranded RNA binding
protein kinase inhibitor activity
protein serine/threonine phosphatase
activity
protein phosphatase binding
RNA polymerase II transcription cofactor
activity
peptide-lysine-N-acetyltransferase
activity
structure-specific DNA binding
Rab GTPase binding
mRNA binding
protease binding

3
2.39794
2.154902
2.39794
3
3
2.522879
3
3
2.154902
3
3
3
3

5.9. Pathway enrichment analysis
In modern molecular biology, identification of associations between an input set of gene and
annotated gene sets (e.g., pathways) is an important problem. Tailor pipeline identified 39
differentially expressed pathways and Ubiquitin-mediated proteolysis is the most
significantly differentially expressed pathway (Fig. 5.9). ECM deposition is the common
feature of fibrotic disease which interrupts the normal structure of the affected organs and
leading to their dysfunction and failure. Degradation of protein via the ubiquitin-proteasome
system is the significantly differentially expressed pathway that controls many critical
cellular functions including cell-cycle progression, cell growth, and differentiation (Chen and
Dou 2010). Anomalous alterations of expression of genes associated with proteasome
pathway dysregulated cellular homeostasis and development of cancers, fibrosis, and
neurodegenerative disorders, etc. Although the ubiquitin-mediated proteolysis mainly
investigated in the field of cancers, recent transcriptomics of stromal fibroblast cell line data
analysis revealed ubiquitin-mediated proteolysis may provide a rational basis for the
discovery of novel therapy for fibrotic diseases and the consisted genes of this pathway are
the part of multi-subunit RING-finger type 3 Cullin-RBX E3. Cullin proteins are molecular
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scaffolds and essentially responsible for the assembly of Cullin-RING ubiquitin ligases
(CRLs) that leads to ubiquitin-mediated proteolysis by facilitating the covalent attachment of
ubiquitin group to target proteins. SEC31 is the target substrate of the Cullin-RING ubiquitin
ligase complex.

SEC31 monoubiquitination by CUL3-KLHL12 is necessary for the oversize COPII vesicle
formation (Patalano 2018) and genes encoding the CUL3, KLHL12, and SEC23 proteins
were differentially expressed by CXCL12- compared to TGFβ- treated cells. Other genes
such as SCAP that preferentially up-regulated by the CXCL12/CXCR4 axis and associated
with COPII vesicle-mediated ER-to-Golgi protein secretion (Patalano 2018); finally, it may
be concluded these group of genes have a prospective role of CXCL12/CXCR4-mediated
initiation of COPII vesicle formation and fibroblast to myofibroblast phenoconversion.
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CHAPTER 6
DISCUSSION
There were many contributors that are involved in the metabolic disease and NAFLD disease
progression. These factors may need to understand that can aid to diagnosis of these diseases.
Previous studies suggested SAMP6 mice are associated with type 2 diabetes mellitus
(Gharaee-Kermani 2013). In our current work, we have mainly elucidated the transcriptional
regulation of genes that are associated in NAFLD. Now to initiate the NAFLD and the other
associated diseases, inflammation play a pivotal role. In HFD-fed mice compared to LFD-fed
mice analysis, several genes were overexpressed, and it’s expected to find some significantly
differentially expressed genes that were associated with metabolic syndrome-induced
inflammation of liver. In addition to this, we have also observed several downregulated genes
that might expect to play liver organ dysfunction. On the other hand, cell signaling pathway
identification is also a main target in our analysis to know how HFD fed mice associated with
liver disease. In our analysis, HFD-fed mice, the significant “PPAR-Gamma signaling
pathway” was the top up-regulated pathway. Accumulation of excess white adipose tissue
(WAT) can lead to develop inflammation, metabolic syndrome, type 2 diabetes, and NAFLD
(Jung and Choi 2014). In SAMP6 mice accumulation of excess WAT or fat has been
observed compare to the low-fat diet mice. This can be an explained due to the direct effect
of excess WAT that may contribute the inflammation aspect. Previously it has been reported
that under the same dietary conditions SAMP6 strain mice are able to progress several
disease concerns (Brenner 2000). As previously reported result from our research group,
these SAMP6 mice espoused type II diabetes which is a risk factor to emerge NAFLD. Taken
together these data it may be concluded that SAMP6 mice model which has been used in this
study, is able to instigate the metabolic syndrome disease which may develop to NAFLD.
Therefore, we have showed, for the first-time alteration of immune-response, downregulation
of metabolic processes that allowed us to study the unique transcriptional response to
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NAFLD, which can aid to understand further knowledge in liver disease and cancer. In this
analysis, we have failed to observe alteration of growth factors, heat shock proteins whereas
elevation of collagen has been observed. This insinuates to the development of early stages of
tumorigenesis and hepatocellular carcinoma which is a unique signature of NAFLD.
Hepatocellular carcinoma and cirrhosis are strongly associated with NAFLD if it’s not treated
(Cholankeril 2017). Though current studies revealed several biomarkers have been identified
that were associated with Hepatocellular Carcinoma, we intended to observe any significantly
differentially expressed genes that may act as a significant biomarker in HFD-fed mice to
LFD-fed mice.
Recent studies showed that deposition of collagen, extracellular matrix (ECM) are
associated with fibrosis that can contribute to the etiology of LUTS. It is reported
microenvironment of aging prostate tissue contained ample amount of inflammatory proteins
particularly CXC-type chemokines (Rodriguez-Nieves 2013) whether these proteins can
mediate fibroblast to myofibroblast phenoconversion is still under suspicion. It is well known
that CXCL12 and TGFβ are inflammatory cytokines and achieved diverse cellular functions
such cellular proliferation and differentiation (Huang 2009). TGFβ is well known pathogenic
effector of fibrosis and it acts as a driving factor to promote fibroblast to myofibroblast
phenoconversion, and ECM deposition (Rodriguez-Nieves 2013). However, in prostate
stroma several C-X-C type chemokines such as CXCL1, CXCL2, CXCL3, CXCL8, and
CXCL12 are altered and secreted and associated with benign hyperplasia (Gharaee-Kermani
2012). Previously, it was reported that, MAP Kinase signaling pathway activated by both
CXCl12 and TGFβ. Previous report suggested TGFβ promoted fibroblast to myofibroblast
phenoconversion in a Smad-dependent manner whereas CXCL12/CXCR4 achieved this
phenoconversion by transactivating EGFR and promoting downstream MAPK signaling
(Rodríguez-Nieves 2016). As a result, activation of these signaling cascades promoted the
activation of the COL1A1 and COL1A2 genes and finally involved in the production of
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procollagen protein. Accumulation of the extra cellular matrix deposition is a characteristic
feature of fibroblast to myofibroblast phenoconversion and hallmark of tissue fibrosis
(Gharaee-Kermani 2012). It is important to understand the underlying mechanism how
CXCL12 and TGFβ concurrently promote fibrosis through transactivating of collagen.
Treated the stromal fibroblasts cells with both CXCL12 and the TGFβ, followed by perform
the transcriptomics analysis reveal interesting result which may be a remarkable feature for
the myofibroblast phenoconversion. The remarkable distinguishing feature is an increased
expression of ubiquitination/polyubiquitination with activation of the CXCL12, compared to
TGFβ. Previously report suggested CXCL12 specifically activates the transcriptional
response in the human prostate and epithelial cells. This activated transcriptional signal
promotes cellular proliferation of stromal prostate epithelial cells which concurrently
activates genes encoding proteins that promotes cellular proliferation (Begley 2008). In this
analysis we have observed several CUL proteins that were over-expressed and in human
these proteins may play an important role to promote CXCL12/CXCR4-mediated cellular
proliferation and myofibroblast phenoconversion. In ubiquitin mediate proteolysis we found
Cul4A is upregulated upon the treatment with CXCL12. In addition to Cul4A, CUL1 is
upregulated in this analysis. So, it is still an unexplored area of research whether these CUL
proteins may initiate to promote CXCL12/ CXCR4-mediated cellular proliferation and
myofibroblast phenoconversion. Another molecular mechanism found in this analysis is
several miRNAs are regulated by both CXCL12 and TGFβ which, in turn, inhibit the
translation of mRNAs. Consistent with our analysis, we are trying to find out whether both
similar and dissimilar subsets of miRNAs are activated by TGFβ/TGFβR axis compared to
the CXCL12/CXCR4 axis because microRNA plays a crucial role in controlling cell
migration and invasion (Baranwal and Alahari 2010). Alteration of miRNAs expression is
widely altered in cancer, suggesting that deregulations of miRNAs are deeply associated in
the development of tumor and cancer progression (Liu 2011). We found miR100HG,
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miR22HG; miR210HG, miR663A, and miR663AHG are upregulated in CXCL12/CXCR4
axis compared to the TGFβ/TGFβR axis. Previous report suggested deregulation of miRNAs
including miR-15, miR-16 have been associated with cancer progression (Liu 2011). So,
further studies are required to decipher whether they promote fibroblast to myofibroblast
phenoconversion. Recent studies from this analysis demonstrated significant amount of long
non-coding RNAs (lncRNAs) which are upregulated in CXCL12/CXCR4 axis compared to
TGFβ/TGFβR axis. LncRNAs are more than 200 nucleotides in length that have deficiency
of protein-coding capacity (Spurlock 2016). LncRNAs regulated fibrosis by deposition of
ECM that concomitantly stimulates the accumulation of collagen and glycosaminoglycans
(Zhang 2018). LncRNAs are a functional and stable part of a genome and plays important
biological roles such as cellular-, structural- processes that direct towards the complexity of
an organism. Based on the stromal fibroblast cell line analysis, we are trying to find out
whether any lncRNAs that may regulate fibroblast to myofibroblast phenoconversion. Our
analysis demonstrated several lncRNAs including MALAT1, NEAT1, TUG1, PTENP1,
Kcnq1ot1, DNM3OS and Scarb2 are upregulated in both TGFβ/TGFβR axis and
CXCL12/CXCR4 axis. So, it’s still an unexplored area of research whether lncRNAs play a
pivotal role in fibroblast to myofibroblast phenoconversion.
Recently, research on miRNAs have been increasingly rapidly. Several studies have
demonstrated that certain miRNAs are specifically correlated with certain cancer and the
different expression level of miRNAs presumably function as an indicator for cancer
metastasis and prognosis. The function of the lncRNA hostgenes MIR22HG and MIR100HG
within this ncRNA ensemble remained elusive. Given the large-scale regulation of miRNAs
in stromal fibroblast, it may possible these miRNAs are directly linked to myofibroblast
phenoconversion. Notably, upregulation of miR100HG and miR22HG, may involve cell
proliferation, migration, and invasion which holds true for the assumption, these miRNAs
play an important role in fibroblast to myofibroblast phenoconversion. Thus, expression
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patterns of miR22HG and miR100HG transcripts implicate an independent, yet unknown
function in the context of myofibroblast phenoconversion. Therefore, loss-and gain function
need to be performed to elucidate the role of these miRNAs in myofibroblast
phenoconversion.
Over the past decade, role of AARS/AARS2 have been overlooked due to their prime
function as a protein translation. However, recent high throughput sequencing provided a
platform to revisit their role. Due to their pleiotropic role in protein translational regulation,
cell signaling and amino acid metabolism, dysregulation of ARS genes has been associated
with tumorigenesis. In this report, we investigated ARS gene expression in human stromal
fibroblast to decipher their role in myofibroblast phenoconversion. RNA-Seq analyses of 9
datasets from stromal fibroblast cell line indicates anomalous expression of ARS in human
fibroblast cell line. Aberrant expression of AARS genes shows upregulation of several AARS
genes such as IARS, IARS2, EPRS, LARS, NARS, TARS, WARS2. The ARS/ARS2 genes
arose early in evolution, and perchance, because of their presence from the beginning, these
genes have been available for adaptation and recruitment to emerging cell signaling
pathways, even those related to cancer. This functional flexibility allows ARS/ARS2 genes to
play role in pathways other than protein synthesis. Clearly, the increase of ARS/ARS2 gene
expression support increased protein synthesis in cancer cells and drives cell transformation.
NARS is also involved in differentiation, presumably contributing to carcinogenesis. NARS,
a class II ARS, identified as an up-regulated protein in this study. Our findings demonstrate
that NARS is involved in cell proliferation, differentiation. Moreover, the current study
demonstrated a novel role of NARS in promoting the migration ability of stromal fibroblast.
On the other hand, WARS2 which is a mitochondrial aminoacyl tRNA synthetase gene
involved in angiogenesis. Angiogenesis is an important factor playing a pivotal role in cancer
cell metastasis and proliferation. Though these ARS/ARS2 genes are often considered as
housekeeping genes recent evidence and our study clearly shows that their basal level of
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expression to carry out normal physiological processes are often perturbed in disease
condition. Our findings indicate that increase of the ARS/ARS2 genes must benefit fibroblast
cells in some way favoring their survival and proliferation. How these genes promote
myofibroblast phenoconversion are working in concert, if any, opens up a new arena of
investigation.

72

CHAPTER 7
CONCLUSION
Emerging technological advances in genomics augmented an enormous amount of data at
unprecedented high resolution (Khatri 2012). High-throughput sequencing of RNA allowed
us to provide simultaneous measurement of RNAs sequence and expression at whole cellular
level (Wang 2009). With the introduction of these new technologies, new bioinformatic
approaches are required to analyze gigantic amount of data. In this thesis we have developed
a pipeline for the analysis of RNA-Seq data and made contributions to the understanding of
diet induced mouse model that are associated with the non-alcoholic fatty liver disease and
the fibroblast to myofibroblast phenoconversion by using the human stromal fibroblast cell
line.
Widespread genome-wide transcriptome study reconciled by high throughput sequencing
technique has revolutionized the study of genetics at unprecedented resolution. Recent
research divulged that an enigmatic amount of regulatory coding and non-coding RNAs
encoded in human transcriptome (Tripathi 2017). Previous report suggested many
unmentionables technology has been developed and categorized these non-coding RNAs as
dark matter” and “junks”. To debunk that idea, RNA-seq is an experimental technique that
has been revolutionized and widely being used for studying non-coding RNAs recently due to
its physiological and pathological significance.
First, we have implemented a complete pipeline to analyze RNA-Seq data. This pipeline
begins by performing a data quality assessment, next it aligns the cleaned reads to a reference
genome, measures the data gene expression level, tests for differential expression and, finally,
concatenates this data into GO terms to find out significant ontology terms that has been
associated with the biological problems. The outcome of this pipeline is a table that contains
the differentially active cellular process between the RNA-Seq samples being processed. This
enables the user to draw patterns for cataloguing gene function from high-volume data.
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Subsequently, we have included a step that can able to investigate if a certain biological
pathway that is significantly differentially expressed on a given RNA-Seq dataset. In RNASeq, the major problem in determining the conclusions is due to the low number of replicate
samples. Lower number of biological replicates in RNA-Seq dataset provides a poor
statistical significance. To overcome this problem, tailor pipeline incorporated cuffdiff step
that perform a differential gene expression analysis. Gene ontology analysis is important to
find the certain biological processes and molecular functions of the differentially expressed
genes and it’s a common approach for the gene set enrichment analysis. The motivation
behind the introduction of Gene Ontology (GO) has grown to be the largest resource of its
type which infers functional relationship of the differential gene. In tailor pipeline we have
added this gene ontology step that will provide the functionality of known and newly
discovered genes. To detect an association between set of input gene and sets of an annotated
gene is a prime interest in molecular biology. To overcome this problem, we have included a
pathview step in the pipeline to identify the differentially regulated pathways. It maps and
delivers user data on relevant pathway graphs based on the array of gene interest. Pathway
analysis is useful for the validation of the conclusions extracted from user biological
problems. It’s hopeful this complete package of pipeline can be useful not only for
bioinformaticians but also for biologists in the future detect novel gene and their target
pathway associated with any biological phenotype.
To evaluate the developed tools, we have studied two biological problems such as a diet
induced SAMP6 mouse RNA-Seq dataset and the stromal fibroblast cell line dataset to study
the myofibroblast phenoconversion. In the diet induced SAMP6 mice system transcriptome
was collected from population of cells infected with high fat diet and low-fat diet. On the
other hand, transcriptomics analysis performed on stromal fibroblast cell line data set which
is characterized by the induction of CXCL12 and TGFβ.

74

Regarding the analysis of these datasets with the developed pipeline, it was possible to
extract biological meaningful conclusions. To initiate metabolic syndrome, fat, high blood
pressure, and elevated glucose levels are the key factors to promote metabolic syndrome in
diet induced SAMP6 mice model system which concurrently initiate to develop diabetes,
heart disease and finally cancer. Understand the transcriptional landscape is an important
factor that can able to diagnose of these diseases. Until date, several studies reported that
development of metabolic syndrome has been shown to be very closely associated with lack
of physical activity and consequently it provides a tendency to rise of obesity rates among
adults. Often NAFLD highly associated with the development of metabolic syndrome that
can lead to liver dysfunction, cirrhosis of liver, and hepatocellular carcinoma. Previous
studies showed SAMP6 mice can develop type-2 diabetes, a key factor to reduce the quality
of life and health of the mice. We are trying to investigate how NAFLD affect the
transcriptional landscape in liver pathophysiology. Transcriptomics analysis of HFD-fed mice
showed many genes were up-regulated when compared to LFD-fed mice and associated with
inflammations. It insinuates us to find any immune-related genes in our dataset that might be
correlated between metabolic syndrome and inflammation which is not previously been
stated. Additionally, this analysis showed some down-regulated genes associated with
metabolic processes, which was able to point towards the fatty liver organ dysfunction. On
the other hand, in HFD-fed mice, the significant up-regulated “PPAR-gamma signaling”
pathway was the top up-regulated pathway in our study. Emergence of next generation
sequencing technology showed HFD induced SAMP6 mice showed liver enlargement with
accumulation of fat which conclude our mice might suffer from NAFLD. Several biological
processes involved in including inflammation, metabolism, cellular stress responses, and
ECM deposition have allowed us to scrutinize this exceptional transcriptional rejoinder to
NAFLD, which can support in further understanding this disease. In our study, we have failed
to find any cancerous or fibrotic phenotype of SAMP6 mice upon treatment with high fat
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diet. However, growth factors such as EGF1, EGF2, and heat shock proteins, and collagen
such as COL1, COL3 so on which have been overexpressed in this study and suspecting they
are associated early stages of tumorigenesis and hepatocellular carcinoma. Finally, we were
able to find the transcriptional association and the hallmark that are associated with NAFLD
and early stages of tumorigenesis. Finally, molecular fibrosis signature associated with
NAFLD disease increases our understanding towards the cellular response in mice model
which is a novel approach towards the better understanding of translational application of the
human fibrosis processes.
To strengthen the reliability of the tailor pipeline, a new dataset, with more robust
information, has been processed by using the developed pipeline described above. In the new
dataset we have aimed tissue fibrosis which is reconciled by the associations of several profibrotic proteins that induce fibroblast to myofibroblast phenoconversion. Previous report
suggested fibroblast to myofibroblast phenoconversion occurs through Smads and MEK/Erk
proteins independently. In this study, we have treated the stromal fibroblast cell line with
TGFβ/TGFβR and CXCL12/CXCR4. Previously, several reports suggested TGF-β1
promoted the transcription of both αSMA and COL1, which is coupled to myofibroblast
phenoconversion. We therefore aimed whether CXC-type chemokines upregulated the level
of αSMA and COL1 expression. Transcriptomics analysis reveals several upregulated
transcripts COL1A1 and COL1A2 genes and resulted in increased levels of procollagen
production, characteristic of myofibroblast phenoconversion. This analysis divulged
unreported pathway name as ubiquitin mediated proteolysis, activates COPII-mediated
vesicle formation responsible for transportation of large cargo complex, from the
endoplasmic

reticulum

(ER)

to

the

Golgi

apparatus.

Therefore,

induction

of

CXCL12/CXCR4 facilitates the procollagen secretion and initiates ECM deposition which is
a characteristic of tissue fibrosis. Several upregulated transcripts reported in this analysis
such as CUL3 and KLHL12 are promoted in increased level of procollagen secretion,
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transported from the ER to the Golgi in prostatic fibroblast. Increased level of procollagen
promotes ECM deposition, hallmark of tissue fibrosis.

Earlier transcriptomics analysis

identified protein-coding genes only. Recently emerging technological innovation upfront
multifarious capability identified uncharacterized ncRNAs, figuring out its biological
significance. Tailor pipeline enables us to identify 15 differentially expressed ncRNAs in the
stromal fibroblast analysis. It is noteworthy MALAT1, NEAT1, TUG1, PTENP1, Kcnq1ot1,
DNM3OS and Scarb2 that were significantly differentially expressed in CXCL12/CXCR4
axis and the TGFβ/TGFβR axis, insinuating us to perform further research to decode their
role in fibroblast to myofibroblast phenoconversion. In conclusion, the results of this study
further highlight the pivotal roles played by ncRNAs in mediating changes in gene expression
and cell functions occurring during pulmonary fibrosis. In particular, our results identified
these lncRNAs as a new determinant of prostatic fibrosis and mechanistically ascribed its
profibrotic effect to the regulation of myofibroblast phenoconversion leading to CXCL12 and
TGF-β-dependent activation of stromal fibroblasts. We thus anticipate this analysis may
represent a new effective therapeutic option to treat fibrosis in the future. Recent report
suggested that over expression of MALAT1 may contribute to the development of fibrosis in
non-alcoholic steatohepatitis (NASH) in liver through mechanisms involving inflammatory
C-X-C motif chemokine ligand 5 (CXCL5) (Leti 2017). It may be concluded that potential
consequence of myofibroblast phenoconversion may be associated with impaired smooth
muscle activity, disrupted smooth muscle function and consequently deposition of ECM.
To regulate gene expression at the post-transcriptional and translational level, miRNAs
play an important role (Morris et al. 2004). Based on gene ontology and literature mining,
revealed their involvement to regulate cellular proliferation and cellular growth. In this study,
miR22HG and miR100HG are presented strong evidence these miRNAs expressed
significantly. However, their role in the context of myofibroblast phenoconversion and
accumulation of ECM is still an open area of research and whether under-expression of
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MIR22HG and MIR100HG have the optimal specificity and sensitivity for liver cancer
diagnosis also needs future confirmation.
From this analysis it is clear that not all ARS/ARS2 genes are altered in cancer rather
that they are cancer specific. This is presumably due to the codon bias for the oncogenes
specific for a cancer. WARS2, though suspected, has never been implicated in fibrosis
earlier. We provide here direct evidence of anomalous WARS2 and NARS expression in
myofibroblast phenoconversion. In general, our study collectively implies that genes like
AARS/AARS2 which are often designated as housekeeping are dysregulated in disease
condition and plays an important role in cancer cell survival/proliferation.
The pipeline described in this thesis will provide a new arena in the field of genomics
research. With the rapid advancement of sequencing technology coupled with augmented
knowledge of the role of genomics in human disease, speeded up for the diagnosis for
patients. We believe, the increasing 'mainstreaming' of whole genome sequencing is
important of genomics research for many clinicians. Hope tailor pipeline will endow with a
genomics research and its clinical applications, including its contribution to personalized
medicine.
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